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Abstract
An assessment is made of the effects of an antiepileptic 
drug, diphenylhydantoin sodium on the performance of 20 
normal subjects. The subjects were presented with a binary 
classification task. Performance in the drug condition was 
compared with that in the placebo condition. The primafy 
dependent variable was the response accuracy. Although 
the .subjects were given instructions which stressed.speed 
of decision, reaction time was not measured. The analysis 
of the data revealed that the drug enhanced performance 
by reducing the number of errors made.
In order to understand the effect of the drug on 
performance better, it was necessary to obtain a much more 
detailed account of the subjects’ performance.
In a second experiment, error rate and reaction time 
were measured and related to the complexity of the decisions 
on each trial. The analysis of the data revealed that the 
drug reduced the error rate and the reaction time. This 
effect depended on the complexity of the decisions, and 
the rate at which decisions were made.
The inverted-U hypothesis which related arousal to 
performance changes was presented as a possible explanation 
for the effect of the drug. It is proposed that the drug 
may reduce the level of over-arousal to an optimum level 
and facilitate performance by this normalizing effect.
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INTRODUCTION
As civilization becomes more complex and more 
reliant upon technology, so the man-machine interface v 
increases in importance. Although the human brain is 
superior to machine operations (except in routine 
procedures) possessing more flexibility and adaptability 
to changing situations, it becomes inferior in constant 
attention and decision making conditions. In these 
circumstances, its performance becomes increasingly 
impaired by a combination of psychological factors, of 
which loss of attention is probably the most important.
In many working environments where attention is heavily 
demanded, its loss may lead to mistakes putting many lives 
at risk (e.g.,in the control of atomic power stations, 
aeroplanes).
Man's attempt to manipulate and to improve his 
performance has led him to experiment with chemicals of 
many kinds. The provision of chemical intervention to 
reduce or even to nullify the risks caused by performance 
decrement has become a matter of consideration.
There are two pharmacological possibilities: One being 
to prevent performance decrement, the other being to augment 
the level of performance. In practice it may not be possible 
to distinguish between these two processes , but pharmacologically 
they may be isolatable. A drug acting by preventing the
decrease of the level of performance may show no effect 
on a normal individual whose~level of performance has 
not yet been impaired, whereas, a drug which augments 
performance shows an effect on a normal individual, 
producing a supra-normal level of performance. These 
drugs are known as the stimulants.
The word stimulant is applied to the Central Nervous 
System excitatory drugs, usually implying the heightening 
of arousal. This excitability reflects a balance between 
excitatory and inhibitory influences that is normally 
maintained within relatively narrow limits. Some stimulant 
drugs classified as the convulsants (e.g.,strychnine) can 
increase excitability by blocking inhibition in the CNS.
The other stimulants (e*g.,amphetamine) presumably act 
by enhancing excitation.
Wittenborn (iso ) reviewed the incidence of improvement 
or impairment of task performance by the stimulants, and 
reported that the stimulants showed more improvements than 
any other class of medication in reaction time, Digit 
Symbol Substitution Test, tapping, visual-perceptual tasks, 
cancellation, card sorting and the Critical Flicker Fusion.
In considering the possible usage of these drugs in 
improving performance, it is also necessary to consider 
their toxicologieal effects.
For example, strychnine has no demonstrated therapeutic 
effects, despite a long history of unwarranted popularity 
as a tonic. However, even its tonic effects are obtained
under toxic doses. Its behavioural effect on learning 
has been mainly demonstrated in rodents, and this restricts 
any general conclusions. Its improvement of vision represents 
the only report the effect of strychnine on human,
\
performance (116 ) .
The xanthines represent a group of drugs that has 
been studied extensively. The studies indicate that caffeine 
is the most effective of the xanthines, and it is the most 
commonly used.
Caffeine is a powerful CHS stimulant and excites the 
cortex primarily. Its main action is to produce a mpre 
rapid and clearer flow of thought, and to combat fatigue 
and drowsiness. After taking caffeine one is capable of 
a greater sustained intellectual effort and more perfect 
association of ideas. There is also a keener appreciation 
of sensory stimuli ( 40 ).However, the feeling of well 
being and the increased performance it offers is obtained 
at the expense of decreased efficiency later.
In man toxic reactions may be observed following the 
ingestion of 1 gram of caffeine. These are mainly referable 
to the central and circulatory systems. Insomnia, restlessness 
and excitement and ringing in the ears are the early symptoms 
Pemoline has produced considerable interest as a possible
enhancer of performance. Although it does not belong to 
the stimulant group, it has been found to have some 
stimulating effects in normal humans (157 ). Further 
reports failed to show any improvement in performance
(i44, 13 ). However, there is still no clear evidence 
about the exact effects of this drug.
Amphetamine has powerful CNS stimulant actions in 
addition to the peripheral actions common to sympathomimetic
X
drugs. Its behavioural effects depend on the dose, mental 
state and personality of the individual. The main results 
of an oral dose pf 10-30 mg are wakefulness, alertness, 
decrease of the sense of fatigue, elevation of mood with 
increased initiative, confidence, ability to concentrate. 
Improvements in performance of simple and choice reaction . 
time tasks and tapping have been reported ( 7 ,156 ).
However, when more complex tasks (e.g., Digit Symbol 
Substitution Test) were concerned, no effect on 
performance has been reported ( 7 ). Mackworth ( 89) 
reported that although more work can be accomplished, 
the number of errors is not necessarily decreased. Physical 
performance in athletes has been improved. However, these 
effects are not invariable, and may be reversed by a 
slightly higher dose or repeated usage for a short 
period ( eo ). Higher doses are nearly always followed 
by mental depression and fatigue. Even in usual doses, 
experience of palpitations, headache, dizziness, vasomotor 
disturbances, agitation and confusion have been 
reported ( 173 ).
pThe most striking improvement due to amphetamine 
appears to occur when performance has been reduced by 
fatigue and lack of sleep. Amphetamine sustains a high 
level of performance over long periods and restores
\
performance degraded by fatigue ( 4 7  ). por example,
Kornetsky et.al.,( 73 ) found that amphetamine improved 
performance in a number of tasks when subjects had been 
kept awake for 68 hours. Such an improvement may be 
partly due to alteration of unfavourable attitudes 
toward the task ( 1 7 3 ).
Amphetamine also reduces the occurrence of micro­
sleeps, the brief losses of vigilance{that impair 
performance after prolonged sleep deprivation and thus 
improves execution of tasks requiring sustained attention ( 60 ). 
Similarly, amphetamine is effective in postponing sleep 
and promoting wakefulness. However, the need for sleep 
can not be indefinitely prolonged. When the drug is 
discontinued after long use, total sleep increases and the 
pattern of sleep may take as long as two months to return 
to normal ( go ).
Because the beneficial effects of the drug have to be paid 
for by fatigue and often depression, risk of side effects 
and toxicity are high in amphetamine, and therefore it 
should not be used indiscriminately.
The conclusion from this very brief summary is that,
u
while the stimulant drugs can enhance performance by
*
augmenting the degree of arousal , their potential 
toxicity is often high. Most.convulsants have not been 
useful in improving performance, due to their lethal 
character.
The stimulants appear to improve performance, although 
this may be due to changes in mood, or reduction in the 
detrimental effects of sustained performance or prolonged 
attention. The only conclusion one can reach for the work 
done with the stimulants is that the problems of design 
and control are so great that findings can not be 
interpreted in only one way. General conclusions are not 
possible. Nevertheless, the toxic effects of the stimulants 
are widely accepted.
To prevent the loss of attention is another possibility 
in the improvement of human performance. A drug acting in 
this way may show no subjective or objective effects in 
the course of a normal individual. However, under fatigue 
inducing situations, such a drug may prevent the loss of 
attention. The name of diphenylhydantoin sodium, an anti­
convulsant drug used since 1938 has been associated with 
such a claim for the last ten years. Previous work had 
tried to establish its efficacy in improving cognitive 
processes. The results of the small number of 
investigations into DPH effects on normal human 
performance have not been unanimous. However in the
dosage range employed for the experimental purposes, DPH 
has proved to be free of any*side effects which can be 
picked up during the course of an experiment. Furthermore, 
at the time of writing, over 1700 reports point to DPH's 
beneficial value on the nervous system in a variety of
V
clinical conditions ( 9 ). Such extensive endorsement 
of its neurophysiological properties provides sufficient 
justification for using it for study; in the present 
investigation. Moreover, the studies in which DPH has 
been found to improve performance are precisely those in 
which the performance itself is relevant to the man-machine 
interface.
The experimental work to be reported in this thesis 
concerns the effects of DPH upon normal human performance 
using a binary classification task with high cognitive 
complexity which satisfies certain methodological criteria.
8CHAPTER 1
Major Methodological Problems of 
Experimental Human Psychopharmacology
V
This chapter will examine some aspects of the methods 
available for studying drug effects on the normal human 
volunteers. The methodological considerations of clinical 
psychopharmacology will not be discussed.
1.1. The Subjects
The reasons for employing normal human subjects in 
drug-behaviour research is different in clinical and 
experimental-psychological research.
The clinical aim is to use normal subjects as models 
for therapy. There are practical reasons for this. For 
example, adequate numbers of psychiatric patients are 
becoming harder to find and administrative barriers to 
their use are rising. Furthermore, the increasing concern 
for the rights of patients makes it more difficult to 
justify giving placebos or withholding drugs during a trial.
However, normal subjects can be recruited in large 
enough numbers for the rapid execution of single-dose 
trials, as well as chronic ones ( 122).
9The experimental-psychological aim is to use drugs 
as tools to analyse normal human behaviour. For this 
purpose, the natural population is the normal subjects, 
and a single-dose trial is generally preferred to a long 
term medication. v
Before subjects can be assigned to experimental 
conditions they must first be recruited. The totality of 
subjects to whom the results of the research are relevant 
is the entire population. Practical considerations dictate 
that the entire population can not be studied. Thus, the 
investigator selects a relatively small section of the 
population (the sample) to represent the population. 
Whatever is seen in the study of the sample should be 
typical of what would have happened in the.population had 
it been studied in its entirety.
One can never be absolutely sure that a sample is 
representative of a population. Elementary methodology 
textbooks suggest that the best approach is to select a 
random sample. On the other hand it is rarely possible 
to select a random sample in real applications, because 
this would need access to the population as a whole, which 
would be difficult to attain. Not only may the investigator 
be denied this access, but it is often unclear how to 
identify the population in its entirety. In reality, a 
sample is selected, because it is accessible to the 
investigator ( 75 ).
The most important right of the human experimental
subject is to participate in the study by his own free 
will and consent. This consent should be given without 
any direct or indirect pressure exerted on the subject 
by the investigator or the circumstances surrounding the 
experiment ( 142 ). %
For normal volunteers, money is among the best ways 
to provide motivation for participation in an experiment. 
Without such a tangible reward there may be the danger 
that the sample might be biased due to the self-selection 
of certain personality types who will volunteer for such 
experiments more often than the "average" person ( so ). 
However, it should also be stressed that, any tangible 
reward offered to prospective subjects should be modest 
enough not to influence them after they have lost 
interest in the study.
A relatively easy way of recruiting subjects is by 
using "captive" subjects, such as the inmates of a prison. 
Although captive subjects may be readily available and even 
complete sampling may be possible, the value of findings 
based on such samples may still be limited and impaired 
if the subjects prove to be uncooperative, poorly motivated 
or irresponsible. It may further be argued that, inmates 
in a prison may represent a special group loaded with 
a distribution of pathological personality types which 
may not as frequently found among self-selected "normal1 
volunteers.
A relatively more difficult way of recruiting
11
subjects is to work with normal volunteer subjects.
Rosenthal and Rosnow ( 134) state somewhat pessimistically , 
that, the existing science of human behaviour may be 
largely the science of those students who enrol in 
psychology courses, volunteer to participate in 
behavioural research, and keep their appointments.
Similarly, McNair ( 97 ) states that, in operational 
terms the "normal" refers to a male college or medical 
student sample about 95% of the time. Moreover, about 
50% of a normal sample consists of paid volunteers.
Berger and Potterfield ( 4 ) define "normal" as persons 
without obvious mental defects, not seeking medical help, 
without complaints of disease and able to function 
adequately in society.
In looking for the primary selection criteria of 
volunteers it is important to assess their ability to 
work with the investigator in determining drug effects, 
to ensure that the sample is homogenous, and that the 
individual differences are minimized.
In this respect, personalities of prospective subjects 
become important, as is an examination of personality 
traits in order to eliminate testees likely to possess 
psychological "disturbance". This can be evaluated by a 
number of different psychometric techniques, such .as the 
MMPI or Self-Report Symptom Inventory ( 23 ), the latter 
being designed especially for use in non-psychiatric 
settings (e.g.,counselling centers and student health centers)
12
and developed principally as a criterion measure in 
psychotropic drug trials. °
Other factors, such as age, social class, weight 
and state of physical health should also he reduced in 
range as much as possible for creating a homogenous sample.
Age has effects on pharmacological and psychological 
responses. Hates of absorption, metabolism and circulation 
of drugs may be related to age.
Dody weight dictates the effects of drugs. Drug dosage 
on a mg/kg basis has given a high degree of reliability and 
reproducibility in drug-behaviour research. Dose response 
based on body weight is a basic concept, and the range of 
body weights of the sample should preferably conform to 
a narrow range of body weights for that particular dose.
Social class is a complicated variable in any drug- 
behaviour research. Rickels et.al.,(129,130 ) accumulated 
evidence which indicates that significant drug-placebo 
differences are demonstrable when a social class factor 
is taken into account. One of the most interesting findings 
is that placebo responses are poorest and drug responses 
best in neurotic middle-class Americans, while the 
reverse is true for low socio-economic neurotic Americans. 
Though such findings are culture-bound, it is still 
important to take the social-class factor into account 
when forming the sample.
Subjects with certain health problems (e.g.,psycho­
somatic or medical disorders) should not be included into
the sample.
The short-term effects of a single-dose may also be 
affected by a history of repeated use of the drug. This is 
especially true for widely used and abused drugs, such as 
alcohol. Mayfield ( 93 ) reported that after the administration 
of alcohol or placebo, nonalcoholic subjects showed 
consistent changes in the Holtzmann’s inkblot responses 
which point towards increased emotional lability and 
impulsiveness. However, alcoholics did not show significant 
changes. Therefore, it may be preferable to exclude 
subjects who have previous experience with drugs or with 
drug-behaviour research.
The strategy employed in the present study may be 
summarized as follows: ;
In the first instance, the Ethical Committee of the 
University was informed of the proposed experiments, and 
was sent a letter describing the research plans. The 
letter referred to previous work, told how many subjects 
were needed and how often they would be receiving the drug.
The intended medication and the doses were named, with some 
explanation of the investigator’s expectations. After the 
Committee approved the plans, statements were prepared 
which would be signed by the subjects, the investigator 
and the supervisor to notify the Medical Director of the 
Student Health Service of the administration of scheduled 
drugs.
Several notices were displayed on various notice boards
in the campus calling for volunteers. The intended 
students were interviewed informally. It was important 
to make sure that they were really willing and suitable 
to participate in the study. After this initial screening, 
the potential candidates were given a date for a more v 
detailed interview and final selection. The objective 
of this meeting was to place the planned study in a 
truthful background for enabling each potential subject 
to decide for himself that he can volunteer, what it is 
that he is volunteering for, and some of the possible 
reasons why he is willing to do so.
During the second meeting, the potential subjects 
were briefed about the experiment. It was emphasized 
that the participation would not be a burden, that it 
would be interesting, and that it would not involve much 
personal sacrifice of time. It was also explained that 
they could continue their normal working day without 
any setbacks. It was necessary for them to abstain from 
alcohol, and not to take any medication for 24 hours 
before their scheduled experimental days.
The financial reward was. carefully explained, since 
it was desired to avoid solely monetary motivation, 
although only a small sum was involved. They were told 
that a gift of 1 Pound would be paid at the end of the 
trials for those who completed the study. The money was 
defined as a "token of appreciation" and definitely not 
as pay.
The nature of the typejof volunteers that were 
needed were explained. Conscientious subjects were needed 
who could fit this work into their schedule and take it 
seriously.
After the project.had been clearly described, those 
who wished not to participate left, and those who wished 
to be considered as subjects stayed for the selection 
interview. The primary objective in this interview was 
to reach a conclusion as to whether a particular subject 
could really participate in the study. A free, open-ended 
conversational interview procedure was prefered, and the 
target points were as follows:
1- Biographic information
2- Medical history and medication habits. The use of 
other drugs, tobacco, alcohol. Psychological disorders. 
Vision (e.g.,colour blindness).
3- Motivation and reasons in volunteering.
4- Equating knowledge of experiment for the subject. 
Reassurance of the subject about the safety of the 
medication, confidentiality of data, his role in the 
total design.
The selected subjects were all postgraduate students 
engaged in their own research and therefore with some 
understanding of the problems involved. It was thought 
unlikely that postgraduate students in the University had 
severe adjustment problems, and are hoping for advice by 
partaking in such a study. As people are not only screened
before being accepted by the University (e.g.,interviews, 
opinion of the referees), such advice can be obtained 
in much easier ways. Therefore, a separate psychological 
inventory was not employed.
y
1.2. The Dependent Variable
The dependent variable is the measure of the possible 
effects of the independent variable, primarily of the 
experimental drug. In this section, the psychological 
tasks, psychophysiological, biochemical measures, and 
subjective ratings will be briefly discussed.
1.2.1. The Psychological Tasks
When the effects of drugs on normal human performance 
is investigated, there is usually the choice of using 
either a laboratory task, or a real-life task for the 
purpose.
When the investigator has the opportunity for choice 
between a laboratory task and a real-life task, there are 
certain considerations which become important in making 
such a decision, including control of variables, the 
realism of the experiment, and the motivation and safety 
of the subjects.
Research in real-life situations has the advantage of
direct implications for similar' situations. Secondly, 
performance by experienced operators on the task is likely 
to be stable, thus reducing the need for extensive 
training. However, there are also disadvantages, such as 
lack of experimental control (e.g.,work stoppages, 
’performance of co-workers, availability of materials, 
cooperativeness of the management).
This does not mean that no worthwhile research can 
be done outside the laboratory. Much valuable information 
has come from real-life studies. Furthermore,, it should 
be desirable to confirm and validate findings from 
laboratory tasks in real-life situations.
This brings about the task construction dilemma: One 
approach to this dilemma asserts the necessity of 
constructing tasks which simulate real-life situations 
as closely as possible to ensure the applicability of 
results to the real world. The other approach asserts 
that tasks should be representative of the basic abilities 
underlying performance, such as vigilance, psychomotor 
coordination, cognition, so that man’s performance 
capabilities could be predicted by the tasks which 
specifically measure these abilities ( 162).
Not all tasks show drug effects. Characterization of 
drugs in ’terms of a standard profile of psychological task 
effects only helps to describe the drugs’ modes of action 
on behaviour. Therefore the reliability and the validity 
of the tasks is crucial in the measurement of drugs’ effects
McNair ( 97 ) surveyed about 100 studies concerning 
the effects of antianxiety drugs on nearly 50 tasks.
He found that the Continuous Performance Test and the 
Digit Symbol Substitution Test were discriminating the 
drug action in about 75% of the cases. Intelligence and 
achievement' type tests were less discriminating. McNair 
concluded with a pessimistic attitude as there was no 
reasonable basis for generalizing about either the 
specific or the comparative effect of these drugs.
Similarly, Kleinknecht and Donaldson ( 71 ) reviewed 
the effects of diazepam on cognitive and psychomotor 
performance, and reported that diazepam effect was not 
seen in reaction time, tapping and sorting tasks.
Wittenborn ( iso) reviewed the effects of several 
drugs on certain tasks. Card sorting, the Digit Symbol 
Substitution Test, tapping, the Critical Flicker Fusion, 
and cancellation showed significant changes as a result 
of hypnotics in more than 50% of the comparisons.
Comparisons involving antipsychotics were few in number, and 
therefore would not support any attempt to distinguish 
between the relative importance of the various tasks.
In the anxiolytics, only the Critical Flicker Fusion and 
hand-eye coordination test showed a significant indication 
of drug effect. The stimulants and antidepressants were 
not examined with sufficient frequency. However, reaction 
time, the Digit Symbol Substitution Test, tapping, 
cancellation tests showed improvement.
These three major reviews clearly indicate that 
some tasks are more sensitive to some drugs than to others.- 
The performance on the psychological tasks enables 
the investigator to reach some conclusions about the 
effectiveness of the drug. However, there is not a one-to-one
V
relationship between tasks and drug effects. Although often 
considered synonyms, the terms '‘action1 and "effect" have 
distinct pharmacological connotations. Fingl and Woodbury (37 ) 
state that most drugs are thought to produce effects by 
combining with enzymes, cell membranes, or other functional 
components of cells. Drug-cell interaction is presumed to 
alter the function of the cell component, initiating a 
series of biochemical and physiological changes. Pharmacologicall 
the initial consequences of drug-cell combination is termed 
the "action" of the drug, the remaining events are called 
"drug effects". In psychology, the term "drug effects" is 
understood to mean the effects on performance abilities 
and observable behaviour, rather than the pharmacodynamic 
sequence. Therefore, an action of a drug may or may not be 
inferred by the performance on the task as such. This, 
creates obvious problems. Drugs which have had no apparent 
effects on performance in one task may have significant 
effects in others. Any lack of drug effects on tasks may 
be due to the relative insensitivity of the task to the 
drug ( iso ). The present state of the tasks which are used 
in drug-behaviour research is far from ideal, therefore 
any drug effects measured by these tasks must be 
discussed cautiously.
1.2.1.a. Cognitive Tasks
These tasks attempt to measure concentration 
(mental effort) and intellectual performance. The primary 
component of the attentional process that is involved in
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the performance of these tasks is the intensive component 
which has been identified by Kahneman ( 67 ) with mental 
effort.
The Continuous performance Test ( 137) is an example 
of a task which requires concentration. When intellectual 
performance is concerned, the Digit Symbol Substitution 
Test (102) is an example of general intellectual ability.
A cognitive task where extreme distraction is 
introduced is the Stroop test in which colour names like 
"red" are printed in conflicting colours, such as green.
The subject is required to name the colours in which the 
names are printed. Subjects find it very hard to 
selectively attend to the colour of the ink and to ignore 
the colour name ( 117 ).
These tasks usually have two important characteristics 
They generally employ stimuli such as numbers or letters, 
and they are carried out under time pressure such that 
maximal levels of concentration need to be applied ( ive ).
1.2.1.b. Psychomotor -Tasks
Psychomotor tasks rely upon the peripheral and 
central mechanisms. Performance with psychomotor tasks
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may be affected by either a central action or a 
peripheral one on skeletal muscle, or a mixture of both 
One of the most common tasks has been the Pursuit 
Rotor test, which consists of a turntable or drum 
revolving at a certain speed. The subject’s task is to 
keep a stylus in contact with a small target embedded 
near the edge of the disc or on the spiral tract of the 
drum. This task requires fine and highly controlled 
muscular adjustments. Primarily large muscle groups are 
involved and the precision of control is measured ( 179) 
Two-Hand Coordination test involves one lathe-type 
control handle which moves a target follower to the 
right and left, while the other control handle moves it 
to and from the subject. By proper coordinate movements 
of both hands, the subject can move the target 
follower in any direction and keep it on a visually 
perceived target as it moves along an irregular path 
avoiding contact with the sides. This apparatus’is 
often a metal box with a S-shaped slit. This task 
measures the ability to coordinate the movements of 
a number of limbs simultaneously ( 5 6 ).
The other psychomotor tasks include tapping, finger 
and manual dexterity tests which involve skillful, 
well-directed arm-hand movements in manipulating 
objects under speed conditions.
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Some psychomotor tasks simulate real-life conditions, 
such as driving. The prototype of driving can be 
simulated in the laboratory by the trail making test.
There are obvious similarities between this task and 
driving, and this task is somewhat analogous to that 
of driving a car on a winding road (i3s). Driving may 
also be measured in a laboratory by means of a driving 
simulator ( 78 ).
Card sorting is also a useful indicator of drug . 
effects as it involves a range of simple and complex 
skills involving both motor and cognitive components. 
Either ordinary playing cards or specially constructed 
cards can be used for the subjects to sort according 
to various conditions, e.g., position, numeral, colour ( 9i
1.2.1.c. Perceptual Tasks
The Critical plicker Fusion is widely used as a 
perceptual task. The Critical Flicker Fusion may be 
defined as the frequency at which a flashing light can 
not be distinguished from a constant illumination (147 ).
Reviewing nearly 100 studies concerning the effects 
of psychotropic drugs on the OFF measures, Smith and 
Misiak ( 147 ) reported that in 63% of the ca'ses the OFF 
measures were found to be significant.
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Other perceptual tasks include After Effects, 
Embedded Figures Test (where the subject is shown a 
particular shape, and then required to locate it in a 
complex pattern), and Speed of Closure Test (where the 
subject's ability to unify an apparently disparate 
perceptual field into a single percept is measured)
( 121 ,103 ).
However these tasks only yield rather esoteric 
information which provides us with a description of 
performance which has limited practical value in 
assessing drug effects.
1.2.l.d. Reaction Time
Reaction time can be defined as the time elapsing 
between the onset of a stimulus and the onset of a 
response as it is registered by the recording apparatus. 
Reaction time tasks generally require little skill to 
perform, as the stimuli are usually easily detected, 
and the response involves some simple action, such as 
pressing a button. Reaction time tasks are generally 
sensitive to changes in attentional efficiency, and 
are sensitive measures of drug action (iso ).
There are several types of reaction time tasks.
In the simple reaction time task, the subject is asked 
to respond as quickly as possible to the onset of a 
pre-defined single stimulus, such as a light. In the 
choice reaction time task, the subject is presented >. 
with one of a number of possible stimuli and he must 
make one of a number of possible responses according 
to a decision rule. The serial choice reaction time 
task consists of a continuous sequence of stimuli, one 
of which is presented at any one time, and a series 
of response patterns. The subject's task is to respond 
with the appropriate pattern as quickly as possible 
after a signal occurs.
A variant of the choice reaction time is the 
binary classification, where there are only two responses 
and a decision rule partitions the stimuli into two 
mutually exclusive classes. Any differences between 
reaction times to stimuli that share a common response 
can then be attributed to differences at the level of 
stimulus processing. The rationale behind this is that 
the events occurring between the stimulus and the respons 
comprise a series of independent non-overlapping stages 
of decision making ( 153) and that the times taken by each 
of the stages summate to determine the total reaction 
time.
Binary classification tasks have been used especially 
in information processing experiments ( 31 , 52 , 113 ,141 , 1 5 3 ) 
This task allows the investigator to manipulate the 
cognitive demands of a situation while keeping the motor 
component simple and constant. Thus, the decision process 
as opposed to motor skills, and central as opposed to 
peripheral mechanisms may be investigated more thoroughly 
by this task (1 1 4).
Two studies have special relevance for the 
investigation reported in this thesis.
Venables (1 6 9) reported the use of a task in an 
investigation of personality factors on performance.
The task consisted of 10 stimulus lights (5 on the left,
5 on the right sides of the display panel): 2 white,
2 green, 2 red lights, 2 lights showing the word "yes",
and 2 lights showing the word "no".
The subject's task was to move a pointer from the 
mark in the center of the apparatus to the mark under 
the white light if it is on its own, or has a green light, 
or a light showing "yes" over it. On the other hand, if it 
had a red light, or a light showing "no" over it, the 
subject was to move the pointer to the mark on the
opposite side. After this move, another move back to the
center mark was necessary.
The sequence of lights in the display was selected 
to vary the level of difficulty. The "easy" sequence
consisted of white lights only. The "difficult" sequence 
consisted of all the lights. The probability of each 
light's appearance was held constant, and the right and 
left hand responses were also balanced. A new stimulus 
configuration was presented at 1.5 second intervals for 
the' "difficult" display, and 2 second intervals for the 
"easy" display.
With this experiment, Venables (A69) tried to 
simulate the stimulus conditions met with by a bus 
conductor in the course of his job. It provided a means 
of measuring the subject's reaction to an increase 
or decrease in the rate of presentation, or in complexity 
of stimuli.
Frankenhaeuser et.al.,( 39 ) reported the use of 
a binary classification task in a psychopharmacological 
context. In this task, the subject had to respond as 
follows: Red light— press the right button, green light—  
press the left button, red and yellow lights--press the 
left button, green and yellow lights— press the right 
button. The task assigned the subject to press the same 
side as light in two conditions (when red and green are 
present), and to press the opposite side as light in 
two conditions (when yellow is present).
The authors did not explain the operating 
characteristics of the task, and did not give any data 
pertaining to the different types of decisions that had to 
be made for obtaining a correct response. Furthermore,
the effects of the experimental medication (alcohol) 
on these different decision making states was not explained.
The choice of a binary classification task for testing 
diphenylhydantoin sodium action on performance can be
\
Justified on these grounds:
1- Reaction time is one of the sensitive measures of 
drug action.
2- The experimental task maps well onto the decision­
making activities met in real life.
1.2.2. Psychophysiological Measures
Psychophysiology involves the measurement of those 
aspects underlying physiological mechanisms which are 
available at the skin surface and the relation of these 
to measured aspects of performance.
This statement can readily lead to an expectation 
of a clear one-to-one relation between measured physiology 
and behaviour. However, this is not the case in practice.
Nevertheless, psychophysiological measures can measure 
some variables, such as skin conductance. Electrodermal 
activity can give information about the changes of the 
level of arousal during the action of the drug. Heart 
rate is another variable, but because of its inertness, 
it is riot so easily related to moment to moment changes
in cognitive activity (115 ,104 ie4 ). Pupil size can 
serve as an index of arousal. The pupillograms indicate 
that the peak pupil diameters across tasks reflect 
variations in processing load of tasks ( 24 ,105).
Evoked Potentials provide a more central index
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than other measures, because such activity may be 
precisely time-locked to externally observable events 
such as stimulus onset or response evocation, so that 
a close link can be established between the physiological 
activity and the decision making activity ( 69, 155). 
Several studies have demonstrated a reliable relationship 
between the amplitudes of especially "late" evoked 
potential components and decision making process in 
vigilance tasks ( 54 ,120,150). in particular, it has been 
shown that the amplitude of a late component of the 
evoked potential (variously termed P300 or association 
cortex potential) is directly related to the confidence of 
a decision.
The generation and interpretation of data related to 
psychophysiological measures as a whole depends upon 
specialist knowledge which was unavailable to the author 
therefore no attempt has been made to employ these 
measures in the present study.
1.2.3• Biochemical Measures
The application of biochemical techniques to drug- 
behaviour studies is a prerequisite for the fuller 
understanding of the drug action on performance. At th'e 
present time, the moment to moment control of the 
biochemistry of the CHS is not possible. Therefore, 
a detailed analysis of the relationship between brain 
biochemistry and behaviour is not possible. Although 
with the use of electrophysiological techniques it is 
possible to see in animals the direct relationship 
between neuroelectric events and errors on a 
discrimination task, unfortunately, this is not as yet 
possible in human research. However, this does not 
alter the significance and relevance of using biochemical 
measures as accessory information during drug-behaviour 
studies ( 74 ).
Several analytical techniques, among them the gas- 
liquid chromatography and the thin layer chromatography 
are available. However, these involve complex extraction 
procedures and require relatively large volumes of blood. 
Relatively advanced techniques like the radioimmunoassay 
allows for more rapid, specific, sensitive and reliable 
estimations of serum levels (131).
1.2.4. Subjective Measures
Behaviour inventories and rating-scales used by the 
subject or the investigator are considered as the subjective 
measures. v
Self-ratings by the subject are often subjective 
reports of mood or feelings and may take the form of a 
simple check-list or a standardized scale such as the 
Maudsley Personality Inventory.
The obvious advantage of using a standardized scale 
is that results in one study can be compared with those 
of another.
Personality inventories and symptom questionnaires 
have been criticized for failing to reveal pertinent 
changes, and to give the subject's enduring picture of 
himself and not a description of his present mood. 
Furthermore, such scales are prepared for use for 
psychiatric purposes and obviously the symptoms (i.e., 
the items of the questionnaire) should not necessarily 
apply to normal subjects.
For these reasons, investigators tend to construct 
their own scales to suit a particular experiment, despite, 
the fact that reliability and validity of such a scale is 
not established, and its replication by other investigators 
may not produce comparable results.
The solution to this problem lies in the construction 
of scales which can be used in normal subjects as well.
Self-Report Symptom Inventory ( 23 ) and Clyde Mood 
Scale ( 20 ) serve such a purpose. The latter can be 
used in a wide range of normal and psychiatric v 
populations, and it has been shown to be sensitive to 
drug effects. \
Mood adjective check-lists provide quantitative 
assessments of various dimensions. They are usually 
rated by the subject. They, like other self-report 
inventories assume that the subject is literate, 
motivated and intellectually competent. These check-lists 
are indefinitely repeatable and quick to administer.
The standardized ones are more reliable to use and 
analyse. Profile of Mood States ( 96 ) is such a check-list 
which was designed to be used in normal subjects as well.
One very important criticism for all such scales is 
that their universality can not be judged and their use 
in cross-cultural research bring serious problems of 
translation and interpretation ( 7 2  ).
1.3. The Independent Variable
One of the major problems in behavioural research 
is controlling the many independent variables which may 
be operating to affect behaviour. Accurate interpretation 
of results depends upon the adequacy of control. Drug- 
behaviour experiments may be affected by a wide variety 
of independent variables.
1.3.1. Drug Administration
1.3.1.a. Dose
One of the basic parameters is the quantity of thq 
dose administered. An assumption in drug-behaviour research 
is that, when other conditions are controlled, behaviour 
may vary as a function of dose.
In clinical situations, drugs are generally administered 
chronically over a period of time ranging from days to 
weeks. However, generally single-dose trials are preferred 
when normal subjects are used.
The possible reason for this may be that the initial 
state of normal subjects is different to that of psychiatric 
patients. Besides, studies with long-term medication with 
normals is difficult for keeping a check on regular intake 
and the psychotropic effects may be disturbing. Therefore 
a single-dose trial is adequate for the minimum dose that 
is needed for the research purposes ( 53 ).
1.3.1.b. Route of administration
Whilst the experimental medication consists of the 
administration of a given dose of the drug, its action 
depends on its concentration at the sites where the given 
action is expected. There is no one-to-one correspondence 
between dosage levels and the effects of the drug because
the intensity of the drug effect depend on the route by 
which it is administered, the metabolic pathways along 
which it travels, the stages in which it is processed 
and the rate of processing at each stage ( 37 ).
There are two routes of administration of drugs. '•
One involves the gastrointestinal tract (enteral), and 
the other bypasses it (parenteral). The oral and sublingual 
administration are examples of enteral route. Oral 
administration is the most commonly used one since it 
is the safest, most convenient and most economical route. 
Sublingual administration is also convenient, and permits 
rapid absorption of many drugs, but it is particularly 
sensitive to taste and irritation. Intravenous injections 
and inhalation are examples of the parenteral route. For 
rapid action, intravenous injection is of great use. This 
eliminates the problems of absorption, and the enzymatic 
destruction problems inherent in the enteral route are 
largely eliminated. However, the dangers of physical and 
psychological adverse reactions are unavoidable, and this 
method is largely permitted only to registered medical 
practitioners. Inhalation also produces rapid effects and 
it is useful for self-administration, but its ability to 
regulate the dose may be poor and its use may be cumbersome.
1.3.1.c. Duration of action
Drugs differ in the speed and duration with which they
produce their effects after administration. To avoid 
complex formation of the drug with foodstuffs in the 
stomach and to increase its access to the mucosal wall, 
subjects may be asked to fast for 24 hours before 
ingestion. However, the difficulty of this assignment 
is obvious. Therefore, as a compromise, the drug could 
be taken on a relatively full stomach. The effects of 
the drug may then be reduced in intensity, but it may 
be more prolonged and more uniform in time. For this 
reason, "time after meals" may be an important intervening 
variable. This brings the question of the distribution 
of meal times. The literature seems to imply that lunch 
is the only meal which is followed by a dip in performance, 
and the time of day changes might be a combination of 
post-meal effects ( 6 ).
However, this should not detract the investigator 
for considering the practical applications, since the 
experiments generally take place during the working hours.
Drugs .disappear from the blood and from their site of 
action at a rate proportional to their concentration. Dose- 
response is related to this rate. Effectiveness may increase 
or decrease with time as the drug undergoes chemical changes 
Therefore standardized measures of behaviour taken at 
different times after administration may provide different 
results.
Knowledge of the time of peak drug effect is of 
importance in properly understanding the behavioural
effects of drugs. This peak is generally deduced from 
physiological responses or biochemical measures.
Crucial consideration in all drug-behaviour research 
is the baseline from which changes occur. Drug effects 
must be evaluated not only in terms of direction but 
also in terms of initial state. In a baseline session, 
the performance of the subject should be measured when 
he is drug-free, to establish his initial level of 
performance.
1.3*l.d. Safety
Drugs are useful poisons, and almost any drug even 
in a small quantity may produce adverse effects of some 
type. On the other hand many unpleasant effects of a 
drug may appear when the drug is given in usual level, 
required for research purposes. Such unpleasant drug 
actions are considered as side effects, and are often 
closely related to the desirable pharmacological 
properties of the drug, and can be produced in almost 
any subject. For example, almost any subject may get 
palpitations and unpleasant jittery feelings from . 
amphetamine or may get sleepy from an antihistaminic 
drug ( 21 ).
Single-dose studies do not need medication in excess 
of the required dose for research purposes, therefore 
serious side effects should not be important in magnitude 
or duration.
1.3*2. Placebo
Experimental control refers to the planning of the 
design and other procedures so that an experiment gives 
clear and precise answers to the experimental question'.-
One of the most widely used control conditions in 
drug-behaviour studies is the placebo. The placebo is 
usually an inactive substance which resembles in perceptibl 
qualities (form,taste,smell) the drug with which it is 
being compared. It is used by the investigator for 
controlling some of the factors which may influence the 
dependent variable. A "pure" placebo is inert, an "impure" 
or "inactive" placebo is a sub-effective dose of the 
active drug.
The mere fact of administering a drug usually produces 
unmistakable suggestive changes in almost all of the 
dependent variables ( 110). Therefore the placebo has 
become closely identified with attempts to control 
suggestion. The administration of a placebo is one aspect 
of double-blind procedure. This is employed to ensure that 
neither the subject nor the investigator know whether a 
placebo or a drug is being administered on any experimental 
condition.
Knowledge of the drug assigned to a particular subject 
may influence the investigator as well as the subject. The 
investigator, as objective as he may believe himself to be,
is eminently suggestible because he wishes to verify 
the hypothesis which he has posed. If he has chosen to 
carry out a particular comparison, he may do so in the 
hope of demonstrating the superiority of one drug over 
others. Therefore "blindness" on the part of the \
investigator eliminates the possibility that he may, 
consciously or unconsciously, convey to the subject the 
stage at which he expects a particular reaction to 
occur ( 158). However, skilled observers can not stay 
"blind" for long (175). While they may not discriminate 
between closely related drugs such as amphetamine and 
caffeine, they perceive the effects as one or the other 
against placebo. Thus, the double-blind procedure may 
become of uneven value, being more useful with some 
drugs or dosages than with others.
There has been a persistent effort to identify the 
so-called "placebo reactor" (38 ,84 ). The bulk of the 
research has been based on a personality trait theory 
approach. Gallimore and Turner ( 4.2 ) reviewed the 
literature and reported that over 20 distinct personality 
traits have been put forward as possible correlates. The 
one personality trait found to correlate with placebo 
responsivity frequently and reliably is chronic anxiety ( 34  ).
1.3.3. Design
i
A between-subjects design requires large number.of 
subjects and that there is no systematic bias in the 
assignment of subjects to conditions. In this design,
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subjects may be randomly assigned to a session and 
attend only once. A major difficulty in this design is 
in obtaining a large enough number of homogenous subjects. 
After the assignment of a subject to a condition, he may 
be obliged to attend at a particular session designated 
by the investigator.
A within-subjects design requires only one group of 
subjects* participation in all experimental conditions and 
to serve as their own controls. The effects of variability 
due to age, body measurements, individual metabolism, 
personality etc are compensated. The reason for this is 
that the random variability of a single subject from one 
measuring period to the next is usually less than the 
variability introduced by measuring and comparing different 
subjects (98). In this design, fewer subjects are required, 
and a single group of subjects would receive one drug, 
perform the task, and wait until the effects wore off.
Then a second drug would be administered, the task would be 
performed. This same procedure would be repeated until 
every subject in the group had received every drug.
The use of this procedure brings up problems with 
regard to the order in which conditions will be presented
to the subject. Thus, it might be that there appears a 
general practice effect, or alternatively a negative practice 
effect. A scheme for balancing order of presentation is 
the crossover technique.
The simplest of crossover technique is to give dru'g A 
and drug B consecutively and determine the order of 
administration by chance. In place of one of the drugs, 
placebo can be given. In this type of design, there are 
two groups of subjects. One group which starts on drug A 
and receives d r u g B  afterwards, and one group which is 
given drug B first, followed by drug A.
Poulton and Freeman ( 123) have critically assessed 
the carryover effects of the crossover design. The effect 
of practice on the second session is implicitly assumed 
to be symmetrical. That is, after condition A, condition B 
is performed better. Similarly, after condition B, condition 
A is improved by the same magnitude. The total for the 
group remains the same. This transfer may also be negative, 
but it is assumed that, either negative or positive, it is 
equal in both magnitude. However, Poulton points out that 
transfer need not be symmetrical. Two types of asymmetry 
are identified: One Way, and Two Way asymmetrical transfer 
effect.
In One Way,asymmetrical effect operates in one 
direction only. There is a transfer when B follows A, 
but no transfer when A follows B. In this case both group
and condition totals differ by the magnitude of this 
transfer effect, in addition to the intrinsic differences 
between condition A and B. This type of transfer may 
reduce or exaggerate the differences between two 
conditions.
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A typical asymmetrical effect occurs when performance 
is lowered under stress situations during the first 
session, and only marginally improves when the second 
session is given under normal conditions, while subjects 
who are first tested under non-stress conditions perform 
at a higher level, which is only slightly debased in a 
subsequent test under stress conditions ( 7 9 ).
In Two Way asymmetrical transfer effect, both orders 
of presentation show transfer effects but these effects 
are equal and opposite. If B following A shows a transfer 
effect of x, A.following B shows a transfer effect of -x. 
Here again such a transfer .effect may augment or diminish 
the real effect of the treatments. The group totals do not 
differ but conditions differ by a factor of 2x.
Another problem in the within-subjects design is its 
limited usage with those drugs where no permanent effects 
can be expected from it. For example, if a drug accumulate 
and if it is excreted slowly, this procedure can not be 
used until all of the first drug has been excreted. This 
might take some time, therefore this would have to be 
determined first, and an appropriate interval, called the 
"wash-out period" introduced into the procedure.
In the Latin Square design, the presentation of the 
conditions are deliberately counterbalanced, and a 
systematic order of presentations is set up so that 
order and carryover effects can be ascertained. The 
prerequisite for the use of this design is that all /
interactions between the conditions should be zero.
1.3*4* Time of day
Fluctuations in human performance have been observed 
to correspond to time of day variations ( 55 ). if the 
performance will be measured on several occasions, 
the times should be counterbalanced for each subject.
The subject may be assigned to an order of attendance 
randomly. For example, the subject may attend at 1200 
hours, and the next session may be at 1000 hours, the 
next at 2000 hours. Sessions may be separated by at 
least a day and at best a week to avoid day of the week 
effects ( 18'). This procedure allows for complete 
randomization of order of presentation and allows time 
of day, and day of the week to be counterbalanced. The 
major difficulty with this procedure is making sure that 
subjects attend all sessions. Another difficulty is that 
an experiment may be measuring performance changes due 
to the inconvenience of attending at a particular time. 
Especially early morning or late evening sessions may 
show worsening performance.
A different approach is to order the attendance of 
subjects in a cyclic way. For example, a proportion of 
subjects may attend in the order 1000, 1200, 1400, 1600 
hours, another group 1200, 1400, 1600, 1800 hours, another 
group 1400, 1600, 1800, 1000 hours and so on. Such a
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procedure can be achieved•by two ways: Either the subject 
has a day or a week between sessions, or the subject 
undergoes the sessions in a rapid succession. Both have 
disadvantages: Rapid succession produce fatigue, slow 
succession may bring problems of nonattendance.
43
CHAPTER 2 
Diphenylhydantoin Sodium
Diphenylhydantoin sodium (abbreviated as DPH) is a 
primary drug for all types of epilepsy except absence 
seizures. It has been more thoroughly studied in the 
laboratory and clinic than any other antiepileptic drug.
DPH was introduced for the symptomatic treatment of 
epilepsy by Merritt and Putnam ( 100). in contrast to the 
earlier chance discovery of the antiepileptic properties 
of bromide and phenobarbitone, DPH was the product of a 
planned research for new chemicals capable of suppressing 
electroshock convulsions in laboratory animals. The 
discovery of DPH was a signal advance for the treatment 
of epilepsy. Since it was not a sedative in ordinary 
doses, it established that antiepileptics need not impair 
consciousness, and it exerted its antiepileptic activity 
without causing a general depression of the CNS.
prom the earliest studies onwards the evidence is 
consistent that DPH corrects hyperexcitability as in the 
post-tetanic potentiation. This normalizing of hyperexcitability 
is achieved without impairment of normal transmission of 
nerve impulses and without initial single impulse being 
affected ( 14 ,86 ,154). This stabilizing effect is probably 
achieved by the decrease in the membrane’s permeability 
to sodium and/or facilitating removal of intracellular
sodium (182). Furthermore, low concentrations of DPH
increase the release of the neurotransmitter ACh
(acetylcholine) and thus may have a role in synaptic
transmission. However, DPH has a Diphasic effect on
the production of ACh, and in higher concentrations it
■ \
inhibits this, synthesis (i68).
Details of the pharmacological action of DPH is 
expanded in Appendix 3-
2.1. Safety
The observations of adverse effects of DPH have 
been conflicting. For example, Kutt et.al.,(77 ) reported 
that as much as 1000 mg could be given safely to patients 
by the intravenous route daily. But Toman ( 161) reported 
that adverse effects are more frequently observed if the 
dose is above 500 mg daily.
Clinical situations where higher doses of DPH is 
chronically used may have only limited relevance to the 
experimental situations where single-dose is generally 
preferred.
In some of the single-dose trials with normal 
volunteers, the subjects did not report any side effects 
(49,145,146). Also, no after-effects have been reported. 
However, Stephens et.al.,( 152) observed that, in their 
trial with 300 mg DPH continued for two weeks, the.drug 
appeared to produce a mildly dysphoric effect in the
female subjects, similar to those produced by minor 
tranquilizers in normal subjects. Levine ( 83 ) also 
reported that, in his single-dose trial with 400 mg, 
some of the subjects complained about an upset stomach 
during the experiments .
2.2. Clinical Studies
Before going into the experimental studies in more 
detail, a summary of the clinical studies carried out 
with non-epileptic patients will be presented..
Merritt and Putnam (ioo) reported that parents 
of epileptic children on the drug noted that the 
children were better behaved, more amenable to discipline 
and better able to work in school.
Within a considerably short time, reports emerged 
about the effectiveness of this drug not only in the 
treatment of epilepsy, but improving the general 
disposition of the patients as well ( 95 ,i35,i6o).
The early studies ( 4i ,68 ) reported that the effect 
of DPH was primarily symptomatic upon states of excitement.
McCullagh and Ingram ( 94.) reported the use of DPH 
for headaches and temper outbursts, and Zimmerman ( 185) 
for behaviour disorders in children. The author found 
that anxiety and impulsiveness were frequently reduced. 
Similarly, beneficial effects on behaviour disorders of 
childhood and adolescence, including hyperactivity and
delinquency has been reported ( 17 , 13G).
Jonas ( 63,64.) and Turner ( 165) reported the use 
of DPH in adult outpatients with psychoneurotical 
symptoms. They emphasized the beneficial effects of DPH 
on irritability, rumination and impulsiveness. The term
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"normalizer" which was used by Turner ( ie.5') seemed to 
be appropriate to describe the drug’s most prominent 
psychological effect, because "DPH did bring about a 
normal quality of being, a harmonious adult ego which 
could shift with external reality much more appropriately 
and ’normally’ than the patient experienced before".
Resnick (127) reported a double-blind study of 
11 prison inmates who had responded favourably to DPH 
in an earlier open trial. 5 subjects received 200 mg DPH 
daily, and 6 received placebo. After one week of 
treatment, the author was able to identify the correct 
medication received by all subjects. The general symptoms 
that improved were anger, insomnia, overactivity, and 
inability to concentrate. The author’s conclusion was 
that DPH seemed to tone down the overactive mind, 
therefore abolishing overthinking, and with it the anger 
and fear as well as many somatic symptoms. However, it was 
evident that this improvement did not outlast the 
administration of DPH.for long, neither did it prevent 
the recurrence of symptoms under environmental stress, 
for instance, a return to the community.
Boelhouwer et.al.,( 8 ) compared the responses of 52
patients with major behaviour disorders to 8 weeks of 
treatment with each of three medications: Thioridazine 
(300-600 mg daily), DPH (300 mg daily) and the 
combination, using a double-blind Latin square design. 
Analysis was limited to assessing the statistical
' y
significance of change on each of the 20 Minnesota- 
Hartford Personality Assay Subscales for the patients 
under each of the three treatment conditions. Patients 
who had abnormal EEG's (positive spiking) showed 
significant change on the most of the subscales with 
the combined treatment, whereas patients with abnormal EEG1 
showed change on the most of the subscales with DPH. No 
analyses directly comparing the 3 treatment conditions 
were reported, and no attempt was made for the explanation 
of results.
Lefkowitz ( 8i ) studied the effects of 200 mg DPH 
daily and placebo on disruptive behaviour in 25 pairs of 
matched male delinquents over a period of 76 days.
Response at the termination of treatment and one month 
later was evaluated in terms of 11 different measures 
and 4 different types of observers. The results with DPH 
were less favourable than those with placebo.
Case et.al.,( 16 ) reported the treatment of 25 anxious 
neurotic outpatients with 200 mg DPH daily and compared 
them to 20 similar patients treated with placebo. They 
found no clear difference in the responses of the two 
groups.
Stephens and Shaffer ( 151) conducted a double-blind 
comparison of 300 mg DPH daily and 15 mg DPH daily in 
30 neurotic outpatients selected for relatively high 
ego strength and intelligence and for symptoms of 
anxiety, anger and irritability. These symptoms, 
especially anger responded more favourably to the higher 
doses of DPH.
Malitz and Kanzler ( 90) reported a double-blind 
comparison of DPH up to 600 mg daily and 6 antidepressants 
in 203 depressed outpatients. Clinical status was 
measured before and after 5 weeks of treatment consisting 
of one week of placebo followed by 4 weeks of experimental 
medication. The response to DPH was significantly worse 
than to placebo on the global scales and the MMPI 
depression scale. The authors suggested that the doses of 
DPH, averaging 429 mg in the last week of treatment, may 
have been high to produce excessive side effects because 
dosages of all medications in the study were pushed 
upwards vigorously as a matter of investigation plan.
2.3* Experimental Studies
Especially relevant to the present study is the 
experimental studies about the effect of DPH on normal 
human performance.
Ilaward ( 4 9 ) used a 150 mg single-dose of DPH and 
placebo on 12 subjects (mean age 20) in a simulated air
traffic control task. A double-blind cross-over design was 
used. The subjects were selected for their complaints 
about difficulties of concentration and obsessive over­
thinking. Each subject received a two hour training on 
the simulator. On two subsequent trials (of 2 hours1 
duration) the subject received either of the medications.
The scores on the second hour of the training session and 
on the second hour of the experimental session were 
compared for the drug and for the placebo separately.
The results showed that there was no difference between 
the scores obtained in the training session and the placebo 
session. However, there was a significant difference 
between the training and the drug sessions at the 1% level, 
and between the drug and placebo sessions at the 5% level.
The results showed that efficiency of performance became 
progressively impaired as a function of time, and DPH 
was found to reduce the impairment in performance due to 
fatigue. This was not achieved by a stimulant effect.
The. author argued that DPH acted on the psychological 
components producing a "normalizing" effect which enabled 
the subject to make more efficient use of his physical 
potential.
Smith and Lowrey (145) used the subtests and scales 
of the WAIS for examining possible changes in basic 
intellectual functions which could be attributable to the 
drug. In this study, 20 normal volunteers took a single 
dose of 200 mg DPH. A double-blind cross-over design was used
As a result, the investigators found that, of the 12 
subtests employed, some showed significant improvement. 
These included the Verbal and Full Scale IQ (significant 
at 1%), Performance Scale, Comprehension and Arithmetic 
Tests (all at 2%). The investigators argued that, \ 
enhancement of generalized mental functions, improvement 
in long-term memory and judgement functions could be 
attributable to the drug.
Idestrom et.al.,( 59) in a carefully controlled 
study, examined the effects of DPH on several psychological 
tasks and physiological variables. The authors also 
monitored the plasma levels of DPH. Two experiments were 
carried out.
In Experiment I, 15 subjects (aged 19 to 29 years) 
took a single dose of 5Mg DPH and placebo in a double-blind 
cross-over design. The interval between the ingestion and 
first testing was 2 hours. The blood samples were 
collected after the testings were complete (4 hours after 
ingestion). The psychological tasks were the Concentration 
test constructed by Diicker, choice reaction time, tapping, 
Critical Flicker Fusion. The physiological measures were 
the skin conductance and tremor measurements. Graphic 
ratings of changes in relation to the baseline in 
concentration, sleepiness, irritability, uneasiness and 
depression were performed. The results showed no effect 
of DPH on any of the tasks or variables. The differences 
between DPH and placebo did not achieve statistical
significance. However, there was higher efficiency in 
the DPH condition when the Concentration test and 
tapping were considered. Similarly, the changes in the 
graphic self-ratings were small and not significant. 
Significant correlations with plasma levels were
V
obtained for mean level in skin conductance. The 
direction of the correlation implied that sedative 
effects of DPH tends to be greater with high plasma 
levels.
In the Second Experiment, 20 subjects (aged 20 to 
28 years) took two doses of 2 .5 mg DPH, 1'7.5 and 11.5 
hours before, and 5 nig DPH 3*5 hours before the testing.
A double-blind cross-over design was used. Additional 
to the psychological tasks used in Experiment I, the 
Mirror Tracing test and the Stroop test were added. The 
physiological measures were the same as Experiment I.
A method of ratio estimation of subjective effects was 
used as a subjective measure. The aim was to compare 
the subjective states in the placebo and DPH sessions 
with each other. The results showed no effect of DPH on 
any of the tasks. However, there was high efficiency in 
the choice reaction time and Critical Flicker Fusion 
scores. When the correlations between the effects and 
plasma levels of DPH are considered, significant correlations 
with plasma levels were obtained only for the Concentration 
test in both experiments. In Experiment I, higher levels 
of plasma level were related to increased concentration.
However, in Experiment II, where plasma levels were 
twice as high, this was related to impaired concentration. 
No significant correlation was obtained between self- 
ratings and plasma levels.
Haward ( 51 ) used a flight simulator and a 
monitoring task simultaneously in a group of pilots 
(aged 22 to 61 years). In a single-blind design, 150 mg 
DPH was used. The testing period was divided into three 
sessions. The first session was for familiarization of 
the subject to the task, the second session was for 
measuring the learning effects that took place in the 
first session. The third session was for experimental 
testing, 1 hour after the ingestion of the drug. The 
results indicated no difference between the first and 
second sessions. However, the whole group showed a - 
statistically significant improvement in performance 
both in terms of speed and accuracy in the third session.
Houghton et al.,(58 ) examined the effects of DPH 
on the Critical Flicker Fusion. 6 subjects (aged 20 to 
33 years) were used in a double-blind randomized design. 
The medications were single-doses of 200 mg or 400 mg DPH 
or placebo. The medication was taken at 0900 hours on 
three separate sessions at weekly intervals. Testing Was 
done at the baseline, and at 1, 2, 3, 5 and 7 hours after 
ingestion. Blood samples were taken after each testing.
No effect of DPH was found on the CFF. The authors 
commented that the absence of any effects suggest that
TA
BL
E 
1.
 
Su
mm
ar
y 
of
 
DP
H 
s
tu
d
i
e
s
01 ■
CQ
rHcti
•H
o
•H
■£>
X!Ph
Xw
©EH
G
bO
•Hm
©Q
a)co
oP
0)
bD<j
©«
H o
O ©
P
P G
' © •H
G P
•H G
©
© a
W ©
© >
© o
P p
O Pr© a
G •H
P P
G G
© ©
o O
•H •H
•H  ' •H
G G
• hO bO
•H •H
CQ- CQ
i
• '* •
© ©•
G
.
G
• . .
© M•
G
■
G
• •
© ©*
G G
• *
© ©• •
G G
P
O
P
©
rH
3 CQa H
•H <CO
o
EH
<
X  O  1 1 X  O| I1 I
G  O
1 1
G  O
bD $
c§ o
in o
V OJ
r- ...
OJ G
1 ©  O
ON © O J
V* a
©
rH
© oa OJ
OJ
■ V
05 10
'
r-l
XI
3o
X I
p
b0o8 
rt ©
p aO *H
P  O  
O G
©  CD
«H O 
CD *H
O <H S3 ©
CO
3  CD O 4J X} P oj ©
o
•H
X  co P M 
© G 
P -H 
O  P  a) 
M  p
co
pH P  
CD CD 
i> P  
CD <H 
t— i ©
rt co P  
0 P  CO
co 3  ©
CO O  he 
H  XJ G 
Ph 4" "H
CD
O
G©
P
O
3
G
G
O
O p
CQ EH 
CD «H
© x  o  g
X> O I I 
G  O
ON
OJ
I
CO
©rH
©a
in
X P<
X
©
bO G
3
O
*rl
X P
p G
t-H ©
© . a
G ©•- >
•O o 8 o
1 p
©  X
•HP  G
O  *rH
P  o
G  ©
P  O ©  P P
O  G o  3 O© © •H  O ©
«H *rl «P o «P
«H O •H  ©© tH G ©
b D GO «H •H G O
S3 © CQ © S3
co
p p
3  CD 
O  P  
X I <H CU ©
Go
*H  
O  P  
•H ©
p  a
©  *H  
«  P  
/ ~ \  ©  •o ©
co
t—108 P 
©  © ©
> C P
© -H <M G 
I—i pH ©  O  
© *H © OT © p  
B  © P  W 
m X  3  ©  
©  O  bO 
H  P X J  O  
p  © CNJ -H
©
o
X
©
©
©
© © ©
H P
X  o I I 
G  o
in
•  *3  bO
o j  c  a  
© in
co
OJi
o
OJ
©
rH
©
a
o
OJ
0510
P PG © 
O P
X  «H
V  ©
X
I
CO
hO
§in
10i
OJ
OJ
©
aON
in
10
-cn.
©  -Gin 
•H r
H iA tn  p  
©  P p . ©  
.co OJ 3  P  
© •* O *H 
CQ v  X  ©
G
O
•H
P  tt )
©  G
rH  -rH
3  P
a  o
•H  P
©  *H Ph
G Ph
P  O O
x  a
bD
•H  G
rH  G
Ph ©
ao
X  G  
I G 
G  © 
P
hO bO
a  a
88 
OJ 4-
m
tni
o
OJ
10
oo
10
©
©
o
•rH
po
XPr10
G
08
Eh«
G
©ra
©
©
Po
GH
MGSOM
© 08
rH ©  P
©  G  ©
>  -H  O-P G
« ©  rH r«H O •
© rH ©  in ©  -H cd• ©  -  p •
G a © CO © W Q
3 X  r P  ©
P  OJ 3  bp 
© P  - o G
CQ ©  v  X  •H
P
CO
©
p  ©
K  p  
10 W X ro w o © 
© p  p  cq p  
G G co 
•H ©  ©  ©  X i 
G  P P  rH O 
© © N O  
© GirH N p  
p  p, © 3  p
to <J >  Ph to
© < r \ / - \
O X G  OG
X o 
I IG O
KN
£
o
r*
G
© OJ 
© OJ
a
© 
rH 
© © 
t-H a  
© © 
a  <h o o- om
A
b
b
r
e
v
i
a
t
i
o
ns
:
 
d-
b:
 
d
ou
bl
e-
bl
in
d,
 
c
-
o
: 
cr
os
so
ve
r,
 
CP
F:
 
Cr
it
ic
al
 
Fl
ic
ke
r 
F
u
s
i
o
n
L
0
M
S
: 
Lo
rr
 
Ou
tp
at
ie
nt
 
Mo
od
 
Sc
al
e,
 
0S
CL
: 
Ou
tp
at
ie
nt
 
Sy
mp
to
m 
C
h
e
c
k
 
Li
st
, 
P
P
S
: 
Pe
rs
on
al
 
Fe
el
in
g 
Sc
al
es
.
it lacks sedative or stimulant properties.
Stephens et al.,(i52) investigated the effects of 
DPH on several scales of mood, and psychological tasks.
The authors used 107 subjects (mean age 22) in a double­
blind cross-over design. The dose was chronic: 100 mg DPH
V
three times daily, or 5 mg DPH three times daily (inactive 
placebo) for 2 weeks. The psychological tasks were the 
Steadiness test, Apparent Eye Level test, serial reaction 
time and the Stroop test. The scales of mood were the 
Lorr Outpatient Mood Scale, Outpatient Symptom Checklist, 
and the Wessman-Adler Personal Feeling Scales. The subjects 
too.k either of the medications for two weeks and then were 
tested. After a week of "washout period", they began 
taking the other medication for two more weeks, and then 
were tested. The results indicated that DPH slowed the 
reaction time significantly. No effect was found on other 
tasks. The subjects were significantly less cheerful 
(Lorr Outpatient Mood Scale), and less full of life,less 
receptive, harmonious, loving, self-confident and full 
of energy (Personal Feeling Scales) under the DPH 
condition. The authors did not make any attempt to offer 
an explanation for these results.
The summary of these studies is presented in Table 1.
2.4. Discussion of the Studies
The experimental studies using normal subjects for
examining the effects of DPH on psychological tasks are 
few and far between. The existing studies report results • 
obtained through several different experimental procedures 
and different expectations and aims. Some have been 
undertaken from a purely psychological point of view, 
with interest of the investigator centering on the • 
psychological effects of the drug, whereas some of the . 
others have been undertaken purely from a psychiatric 
point of view, with the interest of using the normal 
sample as a model for clinical populations. For this 
reason, psychological effects have been assessed by some 
tasks and results have been stated only in general terms 
as an increase or decrease in the scores obtained on the 
task.
Subjects: The subjects used in the reported studies 
were all normal volunteers, with an approximate mean of 
25 years of age. In these 6 studies, the only differential 
group of subjects were used by Haward ( 51 ), where the 
subjects were pilots. The only subject group which was
selected according to their personality traits was the 
one used by Haward ( 4 9  ). In Haward1s study, subjects 
with obsessive personality traits were used to test if 
DPH can help persons whose performance has been impaired 
by their obsessive and ruminative thinking.
Dependent variable: Only a small number of tasks 
are discriminatory in drug-behaviour research, when 
psychotropic drugs are concerned. For anon-psychotropic
drug like DPH, the problem is more pronounced and 
generalizations depending on the results obtained from 
such studies are virtually impossible.
Only one study ( 5 9  ) employed a psychophysiological 
measure. The use of .skin conductance would shed light 
on the effect of DPH on arousal.
Two studies (59 ,58 ) took the blood levels of DPH 
into account and traced the time-dependent distribution 
of blood levels. The correlation between blood levels 
and performance scores was important in understanding 
the relations between the ’‘actions” and “effects" of DPH.
Subjective reports have been used in two studies 
( 59 ,152). The scales used by Stephens et al.,(i52) 
were primarily designed for use in psychiatric samples.
It may be argued that they should not have been used 
when dealing with normal subjects.
Independent variable: A single acute dose is 
generally used orally when normal volunteers are employed. 
Chronic doses or other routes of administration may also 
be used. However this type of approach puts the normal 
subject in a situation where his behaviour is interpreted 
as a model for assessment of drug effect in clinical or 
psychiatric populations. Unless the investigator observes 
the normal subject as a model for patients, the more 
acceptable way of administering a drug for experimental 
purposes is using a single oral dose. Stephens et al.,(i52) 
used a chronic dose of 300 mgs daily for two weeks. Their
results were not significant. Although the authors 
did not make any attempt to discuss this result, it 
may be argued that the acute and chronic effects of a 
drug may be quite different, especially in normal 
subjects who are free of medical complaints of disease.
V
.With chronic administration, many of the possible effects 
which are important initially may disappear as tolerance 
develops and the healthy body learns to compensate for 
the drug-induced change.
Time of testing is also related to the dose of the 
drug. The time-action curve of a drug's effects constitute 
a dose-response curve over time. Some of the DPH studies 
took this factor into account ( 51 , 5 8 , 59 ). However, 
the others either did not report this important point, 
or did not take it into account. Time-action curves are a 
source of variability which can affect performance. In 
order to have reliable results, this factor should have 
been considered by the investigators who have not reported 
about it.
The designs used in these studies conformed to the 
conservative psychopharmacological designs: The usage of 
a placebo and a group of subjects acting as their own 
controls. In any of the studies, the possibility of 
asymmetrical effects were not taken into account. This 
was probably due to the unfamiliarity of the investigators 
to experimental psychological approaches which should be 
used in drug-behaviour studies.
CHAPTER 3
Task Construction
The task which was used in the present investigation 
will he explained in this chapter.
A special apparatus was constructed, consisting, 
of a display panel with 6 stimulus lights, 2 associative 
response buttons, and a “correct" light for feedback.
This is connected to a programmer which delivers the
stimulus and a print-out timer which indicates the
correct, incorrect and missed responses. Signals are
programmed by a punched papertape system, with the
sequence codes randomized. Once the signal appears at
the display, it remains on until.the subject presses
the button. The task is externally paced, and the
subject has no control over the signal rate. A centrally
placed "correct" light is used to indicate when the
subject has produced a correct response (See also Appendix 2).
The crucial feature of the display is that on each 
trial a white light located on the' left or the right of 
the display would be illuminated alone, or together with 
(in a proportion of trials) a red or a green light, or a
blue or an orange light.
Before going into the decision rule which partitions
all these lights, the particular words that will be used 
for this process v/ill be defined:
Stimulus configuration: Each one of the light 
combinations which the display can take up. There are 
7 stimulus configurations:
1- White
2- White + Green
3- White + Red
4- White + Green + Blue v
5- White + Red + Orange
6- White + Green + Orange
7- White + Red + Blue
Trial: Any stimulus configuration that appears on 
the display at any time of the experiment.
Session: An experimental situation where a fixed 
number of trials are presented.
Block of trials: Each session is divided into a fixed 
number of blocks for analytical purposes in order to 
examine changes in performance over time.
Condition: An experimental session in which the 
effects of placebo or the drug are examined.
The stimuli could vary in terms of position, colour 
and number on display. The stimulus configurations are 
generated according to the following decision rule:
White assigns the subject to press a button as same 
side as light. Since there are two Whites, when either of 
them is lit, the subject presses the button corresponding 
to the side of the white, i.e., for left White, presses 
the left button.
Red negates the decision about White, and Green 
confirms the decision about White, when a left or a right
White appears with Red, the correct response would be 
to press the button opposite side as White,i.e.,for left 
White + Red, to press the right hand side button, when 
a left or a right White appears together with Green, 
the correct response would be to press the button as
V
same side as White, because Green confirms the decision 
about White.
White + Red and White + Green are the 2-light 
configurations.
In a 3-light configuration, Orange and Blue are 
added to the existing lights. The presence of the Blue 
or Orange can confirm or negate the stimulus state 
defined by the 2-light configuration.
Thus, if a left White appears with a Red and Orange, 
the correct response would be to press a left button, 
because left White + Red assigns the subject to press 
.the right button, but Orange negates this decision and 
requires the subject to press the left button. V/hen right 
White + Green + Blue appears, the correct response would 
be to press a right button because both Green and Blue 
confirms the initial decision. However, when right White + 
Green + Orange appears, the correct response would be to' 
press the left button, because although Green confirms 
the initial decision of pressing the right button, Orange 
negates this and requires the subject to press the opposite 
button as White.
The total number of configurations and the corresponding 
correct responses are listed in Table 2.
TABLE 2. The Stimulus Configurations and Corresponding 
Correct Responses (in parantheses)
1-light
configurations White left (L) White right.(R)
White right + '•
Red (L)
White right +
Green (R)
White right +
Red + Orange (R)
White right +
Green + Orange (L)
White right +
Red 4- Blue (L)
White right +
Green + Blue (R)
Sequence of the stimulus configurations:
The following points were taken into account during 
the preparation of the experimental tape which presents 
the stimulus configurations.
1- Within a session, there are equal number of left 
and right hand responses. This has to be arranged in 
random order in such a way that half of the responses are 
to the left, half to the right.
2- Within a block of trials, there are equal number 
of left and right hand responses.
3- Within a session, the stimulus probability of 
the left White and the right White are 6% each, and all 
the rest of the configurations are 7% each.
2-light
configurations
3-light
configurations
V/hite left +
Red (R)
White left +
Green (!)
White left +
Red + Orange (L)
White left +
Green + Orange (R)
White left +
Red + Blue (R)
White left +
Green + Blue (L)
4- For each experimental session, a different tape 
is generated. In practice, a particular tape, therefore 
a display sequence is always associated with that session. 
For example, the same tape is used throughout the DPH 
session for each subject, but this tape is not used in
y
any other session. Apart from these experimental tapes, 
a training tape is also prepared to be used before the 
experiment.
CHAPTER 4
Experiment I
A gross assessment was made of the effects of DPH
V
(300 mg) and placebo on the binary classification task 
performance of 20 normal volunteers, using a double­
blind crossover design. The primary dependent variable 
was response accuracy. Although subjects were given 
instructions which stressed speed and accuracy, reaction 
time was not measured. Serum concentration of DPH was 
analysed using the radioimmunoassay.
4.1. Subjects
20 subjects took part in the study. None had 
previously taken part in such an experimental study.
17 of them were male, 3 were female. Mean age for the 
group was 27.1 years. All subjects were right handed.
The average v/eight was 61 kilos. 5 of the subjects 
wore glasses all the time.
4.2. Design and Medication
A double-blind crossover within-subjects design 
was used. Each subject was randomly assigned to one 
of the two experimental conditions: DPH (Phenytoin)
300 mg, and DPH 1 mg (serving as an inactive placebo).
Capsules were supplied by Parke Davis and Co. The 
capsule preparation of DPH was the only form suitable 
for this particular purpose, because at least in the UK, 
the tablet form has been found to have variable absorption 
time, which made optimum time of effect unpredictable ( 4 8  ) 
The capsules possess the necessary consistency of v 
absorption time and provide a consistent and suitably 
accurate time of onset. Drug and placebo were identical 
in size, shape and colour, contained in unmarked bottles. 
The code of the double-blind was known only by.the 
supervisor.
Each subject was required to perform the task twice 
on two experimental days which were separated by 10 days , 
The reasons were to allow for a complete washout of the 
drug and to prevent any kind of drug interaction, and to 
avoid the day of the week effect ( is ).
4*3. Procedure
The subjects were requested to avoid drinking any 
alcoholic beverages for 24 hours prior to the experimental 
session, to refrain from smoking, taking any drugs, 
drinking coffee, and to get a '’normal” night's sleep 
before the experimental session.
For the first experimental session, the subject 
reported at approximately at 0930 hours. He had consumed a 
light breakfast. After checking his name and allocation, he
was allowed to become familiar with the apparatus and 
the experimental cubicle. He was engaged in a general 
conversation while the investigator prepared the. 
apparatus for use. The subject was informed about the 
general nature of the task and then instructed in the v 
proper use of the apparatus. The greatest instruction 
time was spent in explaining the different stimulus 
configurations and the decision rule which governs them. 
After this, the subject was given his first training 
on the task. The pilot studies prior to the experiment 
showed that 40-60 trials, in which the subject saw all 
the possible configurations several times was adequate 
to give the subject a clear idea of how to respond to 
them. Therefore in the first training period, the subject 
was given a sequence of 60 trials. He was verbally cued 
when hesitated, and the correct response and the logic 
behind it was explained. Adequate time was allowed for 
the subject to learn the task. In this first training 
period, the subject manipulated the speed of the display 
himself, in the second training period, the same number 
of trials were given, but without cueing or discussion, 
and the task was externally paced. The experimental tape 
advanced at 1 second intervals.
Following the training periods, the experiment began 
with the insertion of the experimental tape which 
consisted of 180 trials. The subject was instructed to 
respond as quickly as possible and to keep errors to a 
minimum.
The tape advanced automatically at 1 second 
intervals. The number of correct responses was recorded 
by the apparatus.
The first experimental session consisted of a 
Baseline session which did not involve any medicationM 
After this session was over, the subject received a 
sealed envelope labelled with his name, and the capsule 
for that day. Having taken the capsule there, he was 
told to return exactly two hours later. This period, 
allowed the drug to reach a peak level in the body ( i3i ). 
The subject was instructed not to take any medication or 
food or drink during this period, and refrain from 
excessive physical activity.
The subject returned two hours later. His blood 
sample was taken from a finger tip and collected in a 
2 ml capacity lithium heparin paediatric blood collection 
tube (polystyrene-orange label). The training tape was 
repeated at 1 second intervals to enable the.subject to 
warm up. The subject performed the second session with a 
different experimental tape. After the session was over, 
the subject was told the time for return next week. The 
instructions regarding the taking of medication until the 
next session were repeated.
The third and the fourth sessions carried a week 
later followed this same procedure. At the end the subject 
received his "token of appreciation" and was not required 
further.
4.4. Experimental Venue
The testing conditions were kept as standard as 
possible. The experiment was carried out in a special 
sound proof cubicle. Ambient conditions were maintained 
constant at optimum levels. Visual distractions were 
minimized, full ceiling recessed fluorescent light 
illuminated the cubicle. Warning signs on the door of 
the room where the cubicle was constructed insured that 
no one entered during the experimentation.
4.5. Temporal Considerations
Each experimental day began at approximately at
0930 hours. The time-line for each session was as follows
. 0930 begin training 
Baseline session.:1000 end training, begin testing
1005 end testing, ingestion of capsule 
1205 blood sampling 
1215 begin training 
Drug/Placebo 1225 end training, begin testing
session: 1230 end testing
4.6.Results
4♦6.1.Errors
The summary of the data obtained in the four 
experimental sessions are presented in Table 3.
TABLE 3. Mean number of errors, standard deviation
of the mean and percentage for the 4 sessions.
Baseline I Placebo Baseline II DPH
Mean: 55.90 53.35 53.75 24.15
S.D.: 16.28 13.48 14.61 10.89
°/o : 31 29 29 13
The percentage of errors in the placebo session is 
greater than in the drug session. A 2-way Anova (Order 
of treatment x Treatment) indicated that, this difference 
in the error rate was significant, and the drug had a 
significant effect on performance (F = 193.7, df = 1,9, 
p ^.001). The Anova also indicated that the order of 
treatment was not a significant factor (p ^.20) (Table 8).
A 2-way Anova (Order of treatment x Treatment) for 
the Baseline sessions indicated that there was not a 
significant difference between them (p ^ . 2 0 ) (Table 9)-
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4*6,2.Cumulative Error Function
The cumulative frequency of incorrect responses 
during the placebo and drug sessions is shown in Figure 1.
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Figure 1. The mean cumulative frequency of incorrect 
responses in the placebo ( □ ) and DPH ( a ) sessions.
The visual inspection of the above graph suggests 
that the two functions are essentially linear and only 
differ in their slopes, so that they diverge. This feature
of the cumulative frequency of errors suggest that in 
the two sessions, the subjects* performance had achieved 
a stable level. If learning was to occur to a substantial 
degree then a positively accelerating function might be 
expected. Similarly, if fatigue were occurring a negatively 
accelerating function might emerge.
4*6.5* Analysis for possible asymmetrical effects
In order to inspect if the data indicates an 
asymmetrical transfer between sessions ( 123) which would 
invalidate an analysis based on a crossover design, 
the data was separated into two subject groups who differ 
in the order of presentation of the treatment sequence:
1st group: Baseline I - Placebo - Baseline II - Drug
2nd group: Baseline I - Drug - Baseline II - Placebo
The summary of the data obtained from the two groups
is presented in Table 4 and 5*
TABLE 4. Mean number of errors, standard deviation 
of the mean and percentages for the 1st Group (N=10).
Baseline I Placebo Baseline II DPH
Mean: 51*40 56.10 54.40 25.90
S.D. : 14*96 15*51 16.76 12.81
°/o : 28 31 30 14
TABLE 5. Mean number of errors , standard deviation 
of the mean and percentages for the 2nd Group (N 10).
- Baseline I DPH Baseline II Placebo
Mean: 53.10 22.40 60.40 50.60
S.D. : 12.99 8.90 17.06 11.23
% : 29 12 33 28
Analysis of the data obtained from the 4 sessions 
with the 1st Group revealed a significant source of 
variance (p= 19.61, df=3,27, p 001)(Table 10). ,
Analysis of the individual conditions using Tukey’s Test 
( 163) revealed significant differences only for the 
comparison between the drug/baseline conditions, and 
the drug/placebo conditions at 5% level. That is, baseline 
and placebo conditions did not differ, and the drug 
condition differed significantly from the other three.
Analysis of the data from the 2nd Group also revealed 
a significant source of variance (p = 22.01, df = 3,27, v K  *001) 
(Table 11). The Tukey test revealed that the placebo and 
baseline conditions did not differ from each other, but 
the drug condition was significantly different from the 
other three at 5% level.
4 .6 .4 . Blood Analysis
After the collection blood samples, the tubes were
stored in a deepfreeze at 4 degree C until analysed.
The samples were then diluted 1:50 with buffer and the 
supernatant solution obtained after centrifugation was 
analysed using a radioimmunoassay technique. This is a 
sensitive technique for measuring substances present at 
low concentrations in biological fluids which has only 
recently been applied to the determination of blood- 
drug levels (131).
The results obtained in the placebo session with 
1 mg DPH revealed that DPH was not present in measurable 
quantities in the blood. The results obtained in the DPH 
session are presented in Figure 2.
M  • •  • •  •  •  • •
o o  o o o 6 c5obo'oocTooo obiJugba'o'o'ijbooub o o o ' o 6 b b o b 6 b o o o o o o o o o o o o o O
O  rH fvj « \c t  CAcO C^CG 0 - 0  r  t <\J t r \  z f  U \ \ ( )  O  CO O 'O  rH (\J fA-U UMO (O O 'O  rH C\| W\ ;) CACO M O O 'O r l ( \ | lO \ ^  lf\CD C ^ C U fl 'O H O j K \ ^  IT\ 
r (  r-4 rH rH rH rH rH rH rH (VI C\J CM OJ CVJ OJ PI CM <V] Ol K \(A  rA K \ N \K V A  hA KN KA 3  lA lA U M A l/M T v
mici'op;rnrn£j/nil
Figure 2. Range of DPH levels in microgram per miligram 
of blood obtained for the DPH group.
A correlation coefficient between the blood levels 
of DPH and the number of incorrect responses obtained in 
the DPH session was calculated for the DPH group. The 
value of r=+.23 found is not significant at 5% level
(critical value = .44, df = 18). Therefore there is not 
a significant correlation between the blood levels and 
performance score (Table 12).
4 .7.Discussion %
1- The experimental results obtained demonstrated
that DPH can enhance performance on a binary classification 
task. The number of errors in non-drug conditions 
(placebo and baselines) were significantly higher than 
in the drug condition.
2- Inspection of the data obtained for the two groups 
of 10 subjects, as separate groups, did not reveal a 
learning trend over the 4 experimental sessions. If 
DPH facilitated the learning of the task, the subjects 
in the 2nd Group, who received DPH on their second 
experimental session, should be expected to sustain their 
level of performance during the subsequent Baseline II 
and placebo sessions (Table 5). In fact, percentage of 
errors rose from the initial 29% in the Baseline I 
session to 33% in the Baseline II session. As the Anova 
confirmed, there is no overall increase in performance 
level for the 2nd Group following the DPH session. Also 
there is no evidence that DPH facilitates the long term 
change in performance level, which is the criterion for 
learning. Furthermore, it is worth noting that the
essentially linear functions obtained for the cumulative 
response curves for the drug and placebo sessions suggests 
that learning did not occur during any session (Figure 1), 
and performance had achieved a stable level. Similarly, 
if fatigue was occurring, a negatively accelerating % 
function would be expected. This also did not happen. 
Figure 1 indicates that no fatigue decrement was observed 
in any of the sessions. It is argued that in the present 
experiment, the improvement in performance with DPH can 
not be attributed to the ability of the drug to counteract 
fatigue. It should be noted that the onset of performance 
decrement due to fatigue could occur later in time. In the 
short duration study undertaken the visible effects of 
fatigue would not be expected.
3- Inspection of the data for the two groups of 10 
subjects on the baseline conditions revealed no evidence 
in favour of the idea that repeated experience, per se, 
of the experimental task improved performance over time, 
and produced an overall trend in performance. It might 
be argued that extended experience and learning will 
improve performance independently of the action of the 
drug. The absence of an overall trend indicated that no 
asymmetrical effect took place.
4- No significant correlation between the blood levels 
and performance scores was found. The interpretation of
this result is not easy, because the relationship 
between blood levels and brain levels of DPH is not 
clear (87 ). There may be a possible difference in 
concentration of the substances between the blood and 
the brain, and this is true for all drugs. For example^ 
studies of cardiac glycosides reveal high correlations 
between blood levels and therapeutic as well as physiologic 
responses, since blood levels measure the concentrations 
of these substances in the fluids that directly involve 
the target tissue ( 3e ). in drugs that affect the brain 
the blood-brain barrier may be an intervening variable.
This complex system of tissues and membranes is interposed 
between the blood and the brain and may change the 
relations between blood levels and the amounts available 
at the brain sites ( 70 ). For some substances, the time 
course and concentrations of a substance in the blood 
seem to accurately parallel the response of the brain, 
but for other substances, penetrance to the brain may be 
limited and the relation between blood levels and a brain 
measure are obscured in degree.
Secondly, the serum level of a single dose gives 
only very little indication of the possible concentration 
of DPH in brain at that time. Animal studies have shown 
that after DPH is completely cleared from the blood 
stream, it may still be in high concentration in brain 
for many hours ( i84).
For all these reasons, the insignificant correlation 
coefficient is not so unexpected.
CHAPTER 5
Experiment II and III
The results of Experiment I indicated that DPH
V
reduced the error rate on a 1-second paced binary 
classification task, in which the subjects had to respond 
to 14 different stimulus configurations, in one 
experimental session lasting 3 minutes.
This finding establishes the effect of DPH in a 
gross way and does not indicate the nature and mechanism 
of this effect. In order to understand the effects of 
DPH on performance, the operating characteristics of 
the experimental task should be investigated in detail.
For this purpose, the following points will be examined:
1- The task presents the subject 14 stimulus 
configurations to be responded to a decision rule. The 
position of the White light assigns the subject to press 
the same side as White, but the accompanying lights may 
or may not confirm this response. Therefore the possible 
responses and the decisions that govern them vary in 
complexity as the configurations vary in position, number 
and colour. One may assume that there should be relatively 
easier configurations, and relatively harder ones. 
Accordingly, the error rates of the relatively easier 
ones should be less than the harder ones. The nature of 
the error rates may give an indication of the simplicity/ 
complexity of the stimulus configurations, and in the last
analysis, the task itself. Therefore, the first point 
to investigate will be the analysis of the error rates as 
a function of stimulus configurations. '
2- Reaction time represents the speed with which a 
person is able to respond to a stimulus when it appear^, 
and thus be regarded as a measure of decision time. The 
duration of the decision time has been shown to vary with 
the number of component decisions leading to a response
( 153). The simple reaction time experiment is a procedure 
which is conceived as permitting direct measurement of 
decision delay. It is a simplification of the choice 
reaction time experiment in the sense that the subject 
is not required to perform computations for purpose of 
selecting between responses. He can respond as soon as 
he attains the detection state. In a choice reaction 
time situation, the subject.must identify the properties 
of the stimulus and thereby select a response category 
which is appropriate.
In the present experimental task, there are one
1-light, two 2-light, and four 3-light stimulus 
configurations and one may expect that these differ in 
complexity which will be reflected in reaction time.
3- The short time period of the task in Experiment I 
precluded assessment of the role that long term learning 
and/or fatigue may exert. The trial length in Experiment II 
has been doubled so as to permit manifestations of 
interactions between number of trials and short term fatigue 
and loss of attention.
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5.1. Experiment II
This experiment attempted to clarify the operating 
characteristics of the task by taking the number of 
errors (incorrect + missed responses) and the reaction,, 
times for each stimulus configuration into account.
5.1.1. Subjects
8 students participated as subjects. 7 of them were 
male, 1 female. Mean age for the group was 20.3 years.
All were right handed, none used glasses, and none had 
been subjects for Experiment I.
5.1.2. Stimulus material
The apparatus and the method of stimulus presentation 
was similar to those for Experiment I. However, there were 
some differences:
1- Recording of the reaction times were made possible 
by some technical adjustments in the apparatus. The 
stimulus configurations were presented at 1 second 
intervals. The responses were recorded within a 900 
milliseconds period following the test stimulus onset.
2- The total number of trials were doubled, and increased 
to 364. The stimulus probability was controlled to be 7% 
for each stimulus configuration.
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3- Recording of the data was changed. The number of 
incorrect, correct and missed responses were recorded 
on a paper tape. The incorrect and missed responses were 
pooled under the term ’’error rate”.
V
3.1.3. Procedure
Subjects performed on the task for a single session- ■ 
lasting 6 minutes. Adequate time was allowed for the 
subject to learn the task. The decision rule was explained. 
Then the subject was given a training sequence of 60 trials. 
The subject was verbally cued when he hesitated, the 
correct response was shov/n and explained. In this initial 
period the subject manipulated the speed of the display 
himself.
In the second part of the training period,the same number of 
trials were given but the task was externally paced with 
an inter-stimulus interval of 1 second. The subject always 
received a feedback for his responses: A green light for 
correct responses, and no light otherwise.
Following the training periods, the experiment began 
with the insertion of the experimental tape which consisted 
of 364 trials. The subjects were instructed to respond as 
quickly-as possible and to keep errors to a minimum. The 
tape advanced at 1 second intervals.
The experiment was carried out in a quiet room.
Visual and auditory distractions were minimum. Y/arning
signs and a red light on the door of the room insured 
that no one entered during the experimentation.
The subjects were assigned to an order of attendance 
which allowed for randomization of the sessions and for 
the time of day to be balanced for all the subjects.
The morning appointments were at 0900, 1000, 1100 and 
1200 hours, the afternoon appointments were at 1300,
1400, 1500 and 1600 hours.
5.1.4. Results
5.1.4a. Error rate
The distribution of errors associated with the 
stimulus configurations are presented in Figure 3«
A 3-way Anova (Response Side x Practice x Configurations) 
(Table 13) indicated that,
Error rate varied significantly with practice
(F = 56.08, df = 1,7, p <.001)
Error rate varied significantly with stimulus 
configurations (F 29.07, df 6,42, p^.OOlJ
Response side was not a significant factor
(••• = .53, d£ = 1,7, p>.20)
Interaction between practice and response side was not 
significant (F= .04, d f = 1,7, p ^ .20)
Interaction between practice and configurations was not 
significant (F= 1.53, d f = 6,42, p ^ .20)
Interaction between response side and configurations was 
not significant (F- = .35, d f = 6,42, p j>.20)
Overall interaction was not significant 
(F = .92,. df= 6,42, p >.20)
Since response side was not a significant factor, 
the data was pooled over response side and the difference 
between the percentage of errors for the 1st and the 2nd 
halves of the session is shown in Figure 3.
Figure 4 shows the cumulative percentage of errors 
in the session. The 182 trial point marks the middle of 
the session. An Anova for the 1st and the 2nd halves 
(Table 14a,b) indicated that there was not a significant 
increase in the percentage of errors for the 1st half 
(F = 1.80, df = 12,84, p^.20), and there was for the 
2nd half (F = 8.04, df= 12,84, p<.001).
5.1.4.b.Reaction times
The frequency distributions obtained from the 
stimulus configurations were generally skewed (Figure 5), 
especially for the 3~light configurations. Because of the 
sensitivity of the mean to extreme scores, which are not 
balanced on both sides of the distribution, the median 
was used as the standard measure of central tendency.
The mean of each subject’s median reaction time performance 
for the stimulus configurations is presented in Figure 6.
A 3-way Anova (Response side x Practice x Configurations) 
(Table 15) indicated that,
Reaction times varied significantly with practice
(3? = 69.19, df = 1,7, p<.001)
Reaction times varied significantly with configurations
(F= 440.66, df=6,42, p <.001)
W hite W hite W hite White White White White
Green Red Green Green Red Red
Blue Orange Blue Orange
Figure 3. The percentage of errors in the 1st and 
the 2nd halves of the session. (Exp.2)
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Figure 4. Cumulative percentage of errors for Experiment II.
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Kesponse side was not significant (F=.10, df=l,7‘, p^.20)
Interaction between practice and response side was not 
significant (F-.55, df=l,7, p^. 20)
Interaction between practice and configurations was not 
significant (F=2.17, df=6,42, p^.05)
Interaction between response side and configurations was 
significant (F=4*06, df=6,42, p<^.005)
Overall interaction was not significant (F=.55,df=6,42,p^>.
Since response side was not a significant factor, the 
data was pooled over the response side and the mean values 
of the subjects’ median reaction times for each configuration 
for the 1st and the 2nd halves of the session is shown in 
Figure 6.
5.1..5* Discussion
This experiment was an attempt to clarify the 
operating characteristics of the experimental task. Two 
main measures were available: Error rates and reaction times.
Error rates varied with the complexity of the 
configurations. It was seen that the error rates increased 
as the configurations became more complex. The lov/est 
error rate was found in the 1-light configuration (22%), 
the intermediate ones were the 2-light configurations 
(32.6 to 39.1%), and the highest ones were the 3-light 
configurations (45.6 to 63.6%)(Figure 3).
Error rates varied with practice on the task. The
increase in the error rate for each configuration give 
a performance decrement. Experiment I failed to show 
a performance decrement possibly because of the shortness 
of the task (Figure 1). The results of Experiment II 
indicates that a performance decrement may appear only v 
with a trial sequence longer than 180 seconds (Figure 3 
and 4).
The measurement of reaction times was not undertaken 
in Experiment I. However, in the present study, reaction 
times of each configuration was measured. The results 
indicate that as in the error rates, reaction times 
varied with the complexity of the configurations. The 
lowest reaction time was for the 1-light configuration 
(329 msec), the intermediate ones were for the 2-light 
configurations (556 to 621 msec), and the high ones 
were for the 3-light configurations (777 to 880 msec)
(Figure 6).
However given a mean of 880 miliseconds, .it should 
be pointed out that very often the subject's reaction 
times will be greater than the 900 milisecond inter­
stimulus interval permitted by the apparatus. The inter­
stimulus interval was always 900 msecs regardless of the 
subject's response. Therefore on a proportion of cases 
the next trial started before the subject has responded to 
the previous trial. As a result of this, the measured level 
of error rate and reaction time were artifactually influenced. 
The enhanced error.rate and reaction times for the 3-light
configurations reflect this situation.
Reaction times also varied with practice on task. 
There were differences between the reaction times for 
the configurations across the 1st and the 2nd halves 
of the task (Figure 6).
5.2. Experiment III
The results of Experiment II raised the serious 
question about the acceptability of the 1-second task 
as a sensitive and sensible measure of drug action. It 
may be argued that, the subject can not respond 
accurately within a 900 millisecond inter-stimulus 
interval, especially when the 3-light configurations 
are concerned. Therefore, the task carries a ceiling 
effect in itself.
The possibility of presenting the task with a 
reduced rate arises from this point. What happens 
when the task presented to the subjects poses the 
same logically complex configurations, but with a 
reduced rate of presentation?
The investigation of this point will be Experiment III, 
in which a new trial will be presented every 5 seconds, 
the subject still being faced with the same task as 
used in Experiment II.
The error rates and reaction times as a function of 
stimulus configurations will be investigated and the 
effects of practice on performance will be examined.
5.2.1. Subjects
8 students participated as subjects. All of them were 
male. Mean age for the group was 20.8 years. All were 
right handed. One used glasses. None had been subjects
for either Experiment I or II.
5*2.2. Stimulus material
The apparatus and the method of stimulus presentation
V
was similar to those for Experiment I and II. The only 
difference was that a new stimulus configuration was 
presented at 5 second intervals, and the correct responses 
were recorded for reaction times up to 4 seconds. A trial 
started with the presentation of a 1-second warning light, 
followed by the stimulus. The total number of trials and 
the stimulus probabilities were the same as in Experiment II.
5.2.3. Procedure
Subjects attended for a single continuous session 
lasting 30 minutes. Adequate time was allowed for the 
subject to learn the task. The decision rule was 
explained. Then the subject was given a sequence of 60 
' trials. He was verbally cued when hesitated, and the 
correct response was shown and explained. In this initial 
training period, the subject manipulated the speed of the 
display himself according to his own pace.
In the second training period, the same number of 
trials were given and the task was externally paced with 
an inter-stimulus interval of 4 seconds. The subject always 
received a feedback for his responses: A green light
yi
followed the subject’s correct responses, and no light 
for errors.
Following the training periods, the experiment 
began with the insertion of the experimental tape which 
consisted of 364 trials. The subjects were encouraged
\
to respond as quickly as possible and to keep errors to 
a minimum. The tape advanced at 5 second intervals.
The experiment was carried out in a quiet room.
Visual and auditory distractions were minimum. Warning 
signs and a red light on the door of the room insured 
that no one entered during the experimentation.
The subjects were assigned to an order of attendance 
which allowed for randomization of the sessions and for 
the time of day to be balanced for all subjects. The 
morning appointments were at 0900, 1000, 1100 and 1200 
hours, the afternoon appointments were at 1300, 1400,
1500 and 1600 hours.
5.2.4. Results
5.2.4 .a Error rate
The distribution of errors associated with the
stimulus configurations are presented in Figure 7.
A 3-way Anova (Response Side x Practice x Configurations)
(Table 16) indicated that,
Error rate varied significantly with practice 
(F = 76.38, df= 1,7, p <.001)
Error rate varied significantly with stimulus 
configurations (F = 113.94, df=6,42, p^.001)
Response side was not significant (F = .01,df = l,7,p^.20)
Interaction between practice and response side was not 
significant (F=.73, df = 1,7, p ^  .20)
Interaction between practice and configurations was 
significant (F = 9-50, df = 6,42, p < . 001) . v
Interaction between response side and configurations was 
not significant (F = .15, df = 6,42, p^.20)
Overall interaction was not significant (F= .12,df=6,42, 
P >-20)
Since response side was not a significant factor, the 
data was pooled over response side and the difference 
between the percentage of errors for the 1st and the 2nd 
halves of the session is shown in Figure 7.
Figure 8 shows the cumulative percentage of errors 
in the session. The 182 trial point marks the middle of 
the session. An Anova for the 1st and the 2nd halves 
(Table 17a,b) indicated that there was a significant 
increase in the percentage of errors for the 1st half 
(F = 4.60, df =12,84, p ^ .001), and for the 2nd half 
(F =2.315, df= 12,84, p<.01).
5.2.4.b Reaction times
The frequency distribution obtained from the stimulus 
configurations were generally normal (Figure 9). In order 
to maintain a standard measure of central tendency, the 
median is used in the analysis of reaction times. The 
mean of each subject's median reaction time performance
for the stimulus configurations is presented in Figure 10.
A 3-way Anova (Response Side x Practice x Configurations) 
(Table 18) indicated that,
Reaction times varied significantly with practice 
(F= 47.39, d f = 1,7, p <.001)
Reaction times varied significantly with configurations 
(P = 1135.22, df = 6,42, p <  .001)
Response side was not significant (F=1.32, d f = 1,7,p ^ .20)
Interaction between practice and response side was not 
significant (F =.98, d f = 1,7, p ^ .20)
Interaction between practice and configurations was 
significant (F=2.87, df=6,42, p^.05)
Interaction between response side and configurations was ' 
not significant (F.= 2.26, df = 6,42, p^.05)
Overall interaction was not significant (F=1.29, 
df = 6,42, p y .20)
Since response side was not a significant factor, the. 
data was pooled over.the response side and the mean values 
of the subjects' median reaction times for each configuration 
for the 1st and the 2nd halves of the session is shown 
in Figure 10.
Summary of the results for Experiment II and III are 
presented in Table 6.
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Figure 8. cumulative percentage of errors for Experiment III.
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TABLE 6 . Summary of the results for
Experiment II and III
Experiment II Experiment
Error rate
Configuration <•001 <.001
Practice <.001 <.001
Configuration x 
Practice ns <.001
Overall interac. ns ns
Reaction time
Configuration <.001 < .001
Practice < -001 < .001
Configuration x 
Practice ns < .05
Overall interac. ns ns
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,5*-2.5. Discussion
The present experiment was a further attempt to 
clarify the operating characteristics of the experimental 
task. The main difference between the present experiment
y.
and Experiment II was the change in the pace of the task, 
the present one using a longer inter-stimulus interval 
than the previous one.
Error rates varied with the complexity of the 
configurations. It was observed that the error rates 
increased steadily as the stimulus configurations became 
more complex. The lowest error rate was for the 1-light 
configuration (5.2%), the intermediate ones were for 
the 2-light configurations (15.3 to 17.9%), and the 
high ones were for the 3-light configurations (25.2 to 
40.8%)(Figure 7).
Error rates varied with practice on task. The 
results suggest that a performance decrement appears 
throughout the experimental session (Figure 8).
Reaction times varied with the complexity of the 
stimulus configurations. The lowest reaction time was 
for the 1-light configuration (329 msec), the intermediate 
ones for the 2-light configurations (558 to 621 msec), 
and the high ones for the 5-light, configurations (771 to 
1329 msec)(Figure 10).
The longer inter-stimulus interval used in the 
present experiment has resulted in obtaining longer
reaction times for the 3-light configurations than were 
obtained in Experiment II. Reaction times varied with 
practice on task. There were differences between the 
reaction times for the stimulus Configurations across 
the 1st and the 2nd halves of the session (Figure 10).v
5.3. Comparison of the two tasks
The results presented below bring together the 
results obtained in Experiment II and III in order 
to facilitate direct comparison of performance on these 
two forms of the task which will be used in Experiment IV 
to investigate DPH effects.
5.3.1. Error rate
Figures 11 and 12 show error percentages on the
1st and the 2nd halves of the two experiments separately.
It will be noted that error rate is higher in 
Experiment II and there is an overall increase With 
practice.
A 3-way Anova (Task pace x Practice x Configurations) 
(Table 19) indicated that,
Pace of the task influenced error rate (F=241.38, 
df = 1,196, P <  .001)
Practice influenced the error rate (F= 261.48, 
df= 1,196, p <.00l)
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figure 11. The percentage of errors in the l~second 
and the 5-second task during the 1st half of the 
session.
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and the 5-second task during the 2nd half of the 
session.
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Configurations influenced error rate (F = 77.81, 
df = 6,196, p<.001)
Interaction between pace and practice was significant 
(F= 4.18, df= 1,196, p<.05)
Interaction between pace and configurations was not 
significant (F= .87, df - 6,196, p ^ >.20)
V
Interaction between practice and configurations was 
significant (F=3.97, df=-6,196, p<.001)
Overall interaction was significant (F=4.88, 
df = 6,196, p <.001)
Increase of error rate with practice:
A 2-way Anova ('fable 20) between the l’st half 
errors x configurations indicated thait, there was a 
significant difference between the error rates on both 
tasks (F= 102.04, df=l,98, p<.001).
A 2-way Anova (Table 21) between the 2nd half 
errors x configurations indicated that, there was a 
significant difference between the error rates on both 
tasks (F= 139*46, df = 1,98,. p <.001).
Cumulative percentage of errors:
Figure 13 shows the cumulative percentage of errors 
in the 1-second and the 5-second tasks. As repeated earlier 
for Experiment II, the cumulative error curve is a straight 
line up to 182 trials, but then becomes positively 
accelerated. The curve for Experiment III is accelerated 
over the full 364 trials.
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Figure 13. Cumulative percentage of errors for 
Experiment II and III.
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5*3.2. Reaction times
F ig u re  14 and 15 show th e  re a c t io n  tim es on the  
1s t  and the  2nd h a lves  o f  th e  two experim ents s e p a ra te ly .
It will be noted that the reaction times are higher in
v
the 3-light configurations, but similar in the others.
A 3-way Anova (Task pace x Practice x Configurations) 
(Table 22) indicated that,
Pace of the tasks influenced the reaction times
(F = 1544*06, df= 1,196, p < .  001)
P ra c t ic e  in flu e n c e d  th e  r e a c t io n  tim es (F= 20.04, 
d f  = 1 ,1 9 6 , p < .0 0 1 )
Configurations influenced the reaction times
(F= 2749*81, df= 6,196, p < . 001)
Interaction between pace and practice was not significant
(F= 3.09, df = 1,196, p>.05)
Interaction between pace and configurations was 
significant (F= 352.78, df = 6,196, p <1.001)
Interaction between practice and configurations was not 
significant (F = .334, df = 6,196, p^.2o)
Overall interaction was not significant (F= *469, 
df = 6,196, p^.2o)
In c re a s e  o f  re a c t io n  tim es w ith  p r a c t ic e :
A 2-way Anova (Table 23)(Task pace x configurations) 
for the 1st half reaction times for both tasks indicated 
that there was a significant difference between the tasks 
(F = 652 .68, df= 1,98, p<.001).
A 2-way Anova (Table 24)(Task pace x configurations) 
for the 2nd half reaction times-for both tasks indicated 
that there was a significant difference between the tasks 
(F = 915.31, df = 1,98, p<\001).
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Figure 14. The mean reaction times for the.1st half of 
the session for the 1-second and the 5-second tasks 
to the nearest milisecond.
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5.5*3.Discussion
The results obtained in the 1-second and the 
5-second tasks were compared and the following points 
emerged:
\
1- An "error" was defined as the incorrect and/or 
missed response to a stimulus. However, this definition 
was only suitable for the 1-second task, since the 
inter-stimulus interval was generally not long enough 
for the subject to make a response, and there were 
missed responses as well as incorrect ones. When the 
5-second task was considered, an error was always an 
incorrect response. A missed response did not occur due 
to the longer inter-stimulus interval used.
The error rate in the 1-second task was higher 
than the 5-second task, since the number of incorrect 
and missed responses were counted as error. Missed 
responses cut off the end of the distribution of 
reaction times, therefore the figure for the mean 
reaction time varies with the number of missed responses.
The significance of this effect can be seen by 
inspecting the distribution of incorrect and missed 
responses in the 1-second task (Figure 16).
It will be seen that, missed responses were almost 
always associated with the 3-light configurations, and 
the percentage of missed responses increased during the 
2nd half of the session.
pe
rc
en
ta
ge
 
of
 
r
e
s
p
o
n
s
e
s
109
32- 
30- 
28' - 
26-- 
24-- 
22 - 
20' * 
18-- 
16-. 
14-- 
12-- 
1 0 - 
8* -  
6 - 
4 • - 
2-
5.
E m
19
f25l
11
:ua
W hite W hite W hite 
Green Red
W liite  White White W liite
Green Green Red Red
Blue Orange Blue Orange
Figure 16. The percentage of incorrect and 
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halves of the session- for the 1-second and 
the 5-second task.
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The interaction of incorrect and missed responses 
with configurations and practice will be examined in the
1-second task of Experiment IV.
2- As for the cumulative percentage of errors, the 
1-second task indicated that, the response curve was a 
straight line up to the middle of the session, and then 
became positively accelerated. However the curve for the 
5~second task accelerated over the whole session.
Therefore the cumulative percentage of errors for the 
5-second task was higher than the 1-second task in the 
middle portion of the session (Figure 15)*
3- Mean reaction times for the 3-light configurations 
were higher in the 5-second task than in the 1-second task. 
However, since a proportion of responses in the 1-second 
task took longer than the 900 miliseconds inter-stimulus 
interval permitted before the start of the next trial,
a direct comparison is misleading. The mean reaction 
times on the 1- and 2-light configurations are comparable 
and have approximately the same mean value.
There was an overall increase in the reaction times 
with practice on both tasks.
CHAPTER 6
Experiment IV
The effects of DPH on a 1-second and a 5-second 
task were examined in this experiment. The error 
analyses and the reaction times associated with the 
stimulus configurations in the previous two experiments 
were obtained without the effect of any drug. These two 
experiments were conducted in order to clarify the 
operating characteristics of the experimental task under 
two different paces. Having established the task 
characteristics, the present experiment was designed to 
investigate the effect of DPH on the error rates and 
reaction times associated with the two task rates and 
stimulus configurations.
Therefore, 10 subjects were tested under a no-drug 
(baseline) condition and a drug (300 mg DPH) condition 
with the 1-second task, and 10 subjects under a no-drug 
(baseline) condition and drug (300 mg DPH) condition 
with the 5-second task.
This design does not" include a placebo condition. 
Experiment I showed no placebo effect over and above 
the baseline or any long term trends upwards in performance 
therefore a placebo was not included in the experiment, 
instead a no-drug (baseline) condition was substituted 
in its place.
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6.1. Subjects
20 students participated as subjects. All of them 
were male. Mean age for the group was 22. All were right 
handed. 5 used glasses. Hone had been subjects for the
V
previous experiments.
6.2. Stimulus material and design
The apparatus and the method of stimulus presentation 
was similar to those for Experiment II and III.
The present experiment contained two groups of 10 
subjects, tested under two different forms of the task, 
who took the same baseline condition followed by a drug 
condition. In the 1-second task, a new stimulus 
configuration was presented at 1 second intervals. The 
correct, incorrect, and missed responses were recorded 
separately for each trial. In the 5-second task, a new 
stimulus configuration was presented at 5 second intervals, 
and the correct and incorrect responses were recorded up 
to 4 seconds. A trial started with the presentation of 
a 1-second warning light, followed by the stimulus.
The total number of trials and the stimulus probabilities 
were the same as in Experiment II and III,i.e.,564 trials, 
and 7% respectively.
6.3. Procedure
The subjects who took the 1-second and the 5-second 
task attended for two sessions: A' baseline session and 
a session when the subject performed under the influence 
of DPH.
Adequate time was allowed for the subject to learn 
the task before the experimental session. The decision 
rule was explained. Then the subject was given a sequence 
of 60 trials. He was verbally cued when hesitated, and 
the correct response was shown and explained. In this 
initial training period, the subject manipulated the 
speed of the display himself according to his own pace.
In the second training period, the same number of 
trials were given and the task was externally paced. The 
inter-stimulus interval for the 1-second task was 
1 second and for the 5-second task 5 seconds. The 
subject received a feedback for his responses: A green 
light for correct responses, and no light for errors.
Following the training periods the experiment began 
with the insertion of the experimental tape which consisted 
of 364 trials. The subjects were encouraged to respond 
as quickly as possible and to keep errors to a minimum.
After the experiment was over, the subject received 
the capsule, and he was told to return exactly two hours 
later. He was also instructed not to take any medication 
or food during this period.
When the subject returned two hours later, the 
training sequence was repeated, where the inter-stimulus 
interval was the same as the one used in the experiment.
At the end, the subject received his "token of appreciation 
and was not required further. ,
The experiment was carried out in a quiet room.
Visual and auditory distractions were minimum. Warning 
signs and a red light on the door of the room insured 
that no one entered during the experimentation.
The subjects were assigned to an order of attendance 
which allowed for randomization of the sessions and for 
the time of day to be balanced for all subjects.
The subjects would either come at 9 AM and come 
again at 11.30 AM, or come at 2 PM and then come again 
at 4.30 PM. The subjects were not given options of times 
to attend the experiment. If this procedure was not 
adopted, there would be a chance of "morning" and 
"afternoon" types attending the morning and afternoon 
sessions respectively as a result of personal preference. 
Blake ( e ) has shown an interaction between personality, 
performance and time of day suggesting that the circadian 
rhythms of introverts and extroverts differ. Similarly, 
Patkai (us) has distinguished performance differences 
between morning and evening people. In this context, the 
subjects in the present experiment were assigned to a 
session on the basis of their verbal reports about their 
working schedules and habits. Subjects who indicated that 
they generally prefer mornings for studying were assigned 
to an afternoon session or vice versa.
6.4. Results for the 1-second task
6.4.1. Analysis of incorrect responses
The distribution of incorrect responses associated 
with the stimulus configurations and practice are presented 
in Figure 17.
A 3~way Anova (configurations x Practice x Conditions, 
i.e.,drug or baseline)(Table 25) on the data obtained 
for the distribution of incorrect responses indicated that,
Incorrect response rate varied with practice
(3?= 19.9, df = 1,9, p <.001)
Incorrect response rate varied with stimulus 
configurations (F = 24.1, df= 6,54, P^*00l)
Incorrect response rate varied with conditions
(F = 74.1, d f = 1,9, p <.001)
Interaction between practice and condition was significant
(F= 14.5, df = 1,9, p^.001)
Interaction between practice and configurations was 
significant (F=6.7, df=6,54, p^.OOl)
Interaction between condition and configurations was 
significant (F = 8.8, df=6,54, p<^.001)
Overall interaction was significant (F=5.3, df=6,54,
p ^ .001)
The difference in percentage of incorrect responses 
for the 1st and the 2nd halves of the baseline and p p h  
conditions are shown in Figure 17. This figure indicates 
that there is an overall increase in the percentage of 
incorrect responses in the baseline and PPH conditions 
when the results obtained for the 1st and the 2nd halves
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Figure 17. The percentage of incorrect responses in the 
1st and the 2nd halves of the sessions for the baseline 
and DPH conditions. (Exp.4, 1-second task)
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of the session are compared, however, the increase in 
the percentage of incorrect responses in the DPH 
session is substantially less than in the baseline 
session.
In order to examine the nature of this difference
V
two partial analyses were carried out.
The first 2-way Anova (Configurations x Practice) 
(Table 26) on the data obtained for the distribution 
of the baseline condition indicated that,
Incorrect response rate varied with practice 
(F = 17.6, df = 1,9, P <.05)
Incorrect response rate varied with the stimulus 
configurations (F = 11.5, df=6,54, p^.001)
Interaction between configurations and practice was 
significant (F=6.4, df=6,54, p^.001)
The second 2-way Anova (Configurations x Practice) 
(Table 27) on the data obtained for the distribution 
of the DPH condition indicated that,
Incorrect response rate varied with practice
(F = .12.0, df = 1,9, P<.01)
Incorrect response rate varied with the stimulus 
configurations (F=28.2, df=6,54, p^.OOl)
Interaction between configurations and practice was 
not significant (F = .86, d f = 6,54, p^>.20)
6.4*2. Analysis of missed responses
The distribution of missed responses associated 
with the stimulus configurations and practice are 
presented in Figure 18.
A 3-way Anova (Configurations x Practice x Conditions) 
(Table 28) on the data obtained for the distribution of 
missed responses indicated that,
Missed response rate varied with practice
(F = 28.4, df = 1,9, p<.001)
Missed response rate varied with the stimulus 
configurations (F = 60.03, df=l,9, p<£.001)
Missed response rate varied with conditions
(F = 408.07, df = 1,9, p<.001)
Interaction between practice and conditions was 
significant (F=11.9, df=l,9, p<^.001)
Interaction between practice and configurations was 
significant (F=11.4, df=6,54, p^.001)
Interaction between conditions and configurations was 
significant (F=34.8, df=6,54, P^-001)
Overall interaction was significant (F=l6.2, 
df = 6,54, p<.001).
The difference in percentage of missed responses for 
the 1st and the 2nd halves of the baseline and DPH sessions 
are shown in Figure 18. This figure indicates that there 
is an overall increase in the percentage of missed 
responses in the baseline and DPH conditions when the 
results obtained for the 1st and the 2nd halves of the 
session are compared. The increase in the DPH session 
is markedly less than in the baseline session.
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In order to examine the nature of this difference 
two partial analyses were carried out.
The first 2-way Anova (configurations x Practice)
(Table 29) on the data obtained for the distribution of 
the baseline condition indicated that,
v
Missed response rate varied with practice
(F = 21.6, df = 1,9, P<-05)
Missed response rate varied with the stimulus 
configurations (P = 51.6, df=6,54, p^.001)
Interaction between configurations and practice was 
significant (P = 16.3, df=6,54, p^.001)
The second 2-way Anova (Configurations x Practice) 
(Table 30) on the data obtained for the distribution of 
DPH condition indicated that,
Missed response rate varied with practice
(F = 20.2, df =1,9, p <.05)
Missed response rate varied with the stimulus 
configurations (P=8.0, df = 6,54, p<^.001)
Interaction between configurations and practice was not 
significant (P = .86, df = 6,54, p^.02)
6.4.3. Reaction times
The mean of each subject's median reaction time 
performance for the stimulus configurations and practice 
are presented in Figure 19.
\
A 3-way Anova (Configurations x Practice x Condition) 
(Table 31) on the data obtained for the subject's median 
reaction times indicated that,
Reaction times varied with practice (F = 112.7, 
df = 1,9, p <  .001)
Reaction times varied with the stimulus configurations
(F = 973.6, df= 6,54, p Cool)
Reaction times varied with conditions (F =559.2, 
df=l,9, p <.001)
Interaction between practice and conditions was not 
significant (F=1.04, df=l,9, p ^ .20)
Interaction between practice and configurations was 
significant (F = 2.3, df=6,54, P^*05)
Interaction between conditions and configurations 
was significant (F = 17.04, df=6,54, p^.001)
Overall interaction was not significant (F= .45, 
df = 6, 54, p >.20)
The difference in the mean values of the subjects' 
median reaction times for the 1st and the 2nd halves of 
the baseline and DPH sessions are shown in Figure 19.
This figure indicates that the reaction times obtained 
in the DPH condition are lower than the ones in the 
baseline condition. This trend is apparent in both halves 
of the session. Although there is an increase in the 
reaction times in the 2nd half, they are still.lower' -
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Figure 19. The mean reaction times for the 1st and 
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when compared to the ones in the 2nd half baseline 
session.
In order to examine the nature of this difference 
between the conditions, and the effects of practice on 
performance, two partial analyses were carried. ,
The first 2-way Anova (Configurations x Practice) 
(Table 32) on the data obtained for the distribution of 
the baseline condition indicated that,
Reaction times varied with practice (F=62.2, 
df = 1,9, p <  .001)
Reaction times varied with the stimulus configurations 
(F = 468.8, df = 6, 54, p <  .001)
Interaction between configurations and practice was 
not significant (p=l.l, df=6,54, p ^.20)
The second 2-way Anova (Configurations x Practice) 
(Table 33) on the data obtained for the distribution of 
DPH condition indicated that,
Reaction times varied with practice (P= 66.4, 
df= 1,9, p <.001)
Reaction times varied with the stimulus configurations
(F = 949.8, df = 6, 54, p<.001)
Interaction betv/een configurations and practice was 
not significant (F=1.5, df = 6,54, . p^.20)
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6.5. Results for the 5-second task
6.5.1. Analysis of incorrect responses
The distribution of incorrect responses associated
V
with the stimulus configurations and practice are 
presented in Figure 20.
A 3-way Anova (configurations x Practice x Conditions) 
(Table 34) on the data obtained for the distribution of 
incorrect responses indicated that,
Incorrect response rate varied with practice
(F = 145.3, df = 1,9, p<.001)
Incorrect response rate varied with the stimulus 
configurations (F= 109.8, d f = 6,54, p X » 001)
Incorrect response rate did not vary with conditions
(F = 3.08, df = 1,9, P>.10)
Interaction between practice and conditions was 
significant (F=12.8, df=l,9, p^.01)
Interaction between practice and configurations was 
significant (F = 25.6 , df=6,54, p^.001)
Interaction between conditions and configurations 
was significant (F = 2.4, df = 6,54, P^»05)
Overall interaction was not significant
(F = 1 .06, df = 6 ,54, p>.20)
The difference in percentage of incorrect responses
for the 1st and the 2nd halves of the baseline and DPH
sessions are shown in Figure 20. This figure indicates 
that the percentage of incorrect responses during the 
2nd half of both sessions was markedly higher than in 
the 1st half. The incorrect response percentage increased
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Figure 20. The percentage of incorrect responses in the 
1st and the 2nd halves of the sessions for the baseline 
and DPH conditions. (Exp.4, 5-second task)
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as 'the complexity of the configurations increased. This 
was the case for both conditions. However there were 
not marked differences between the DPH and baseline 
conditions, and this was confirmed by the Anova.
V
6.5.2. Reaction times
The mean of each subject’s median reaction time 
performance for the stimulus configurations and practice 
are presented in Figure 21.
A 3-way Anova (configurations x Practice x Conditions) 
(Table 35) on the data obtained for the subjects’ median 
reaction times indicated that,
Reaction times varied with practice 
(F= 213.5, df = 1,9, p <.001)
Reaction times varied with the stimulus configurations
( F = 2203-3, df = 6,54, p<.001)
Reaction times were not affected by conditions
(p = 4.8, df = 1,9, P > .05)
Interaction between practice and conditions was 
significant (f = 6.5, df = l,9, P<*05)
Interaction between practice and configurations was 
significant (F= 11.07, df=6,54, p<.001)
Interaction between conditions and configurations was
significant (F=4.2, df=6,54, p<<.005)
Overall interaction was significant (F= 3.7, d f = 6,54, 
p <.025)
The difference in the mean values of the subjects’ 
median reaction times for the 1st and the 2nd halves of 
the baseline and DPH sessions are shown in Figure 21.
A summary of the results for the whole experiment is shown
in Table 7.
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Figure 21. The mean reaction times for the 1st and the 
2nd halves of the session for the baseline and DPH 
conditions. (Exp.4, 5-second task)
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TABLE 7. Summary of the results for
1-sec. task
Incorrect responses
Conditions <.001
Configurations <.001
Practice <.001
Condition x Practice <.001
Practice x Configuration <.001 
Condition x oonfiguration<.001 
Overall interaction
Missed responses
Conditions 
Configurations 
Practice
Condition x Practice 
Practice x Configuration <.001 
Condition x Gonfiguration<.001
Overall interaction .<.001
Reaction times
Conditions <.001
Configurations <.001
Practice <.001
Condition x Practice ns
Practice x Configuration <.05 
Condition x configuration^ 001 
Overall interaction ns
<.001
<.001 
<.001 
< .001 
< .001
Experiment IV
5-sec. task
ns 
<.001 
< .001 
<.01 
<.001 
<.05 
ns
not available 
for this task.
ns 
< . 001 
<•001 
<.05 
< .01 
<.05 
<.02
6.7. Discussion
*
This experiment examined the effects of DPH on the 
binary classification task performance of 20 normal 
subjects. Performance was measured on a baseline and DPH
V
(300 mg) session, using the l~second and the 5-second 
versions of the same task. The parameters measured were,
(1) the number of incorrect responses which occured within 
900 miliseconds from the test stimulus onset in the 
1-second task, and within 4 seconds in the. 5-second task,
(2) the number of missed responses, i.e., omitted 
responses and those occured between 900 and 999 mili­
seconds in the 1-second task, (3) subject's median 
reaction time for the correct responses.
The discussion of the results will be presented 
under the following order: 
a- Conditions
b- Stimulus configurations 
c- Practice on the task
d- Interaction between conditions and practice
e- Interaction between practice and configurations
f- Interaction between conditions and configurations
a. Conditions
1-second task: The effect of the condition was 
significant for the incorrect and missed responses and 
the reaction times. In the DPH condition, the incorrect 
response and the missed response rates were lower than 
in the baseline condition. Similarly, the reaction times
were lower in DPH condition.
5-second task: The effect of the condition was not 
significant for the incorrect response rate and the 
reaction times. A missed response rate was not available 
for this task since this response category did not occi^r.
There was not a significant difference between the 
incorrect response rates in the DPH and the baseline 
conditions. Similarly, the difference in the reaction 
times in the DPH and baseline conditions were not 
significant.
b. Stimulus configurations
1-second task: Stimulus configurations were a 
significant factor for the incorrect and missed response 
rates and the reaction times. The number of incorrect and 
missed responses and the reaction times increased as the 
complexity of the configurations increased.
5-second task: The results were the same as the 
1-second task. Stimulus configurations were a significant 
factor for the incorrect response rate and the reaction times.
c. Practice on the task
1-second task: The effect of practice on the incorrect 
and missed response rate and the reaction times were 
significant. The differences in the incorrect and missed
response rate and the reaction times between the 
1st and the 2nd halves of the sessions were significant. 
The number of incorrect and missed response rate and 
the reaction times increased across the sessions.
5-second task: The results were the same as the 
1-second task. The practice effect was significant fo r v 
the incorrect response rate and the reaction times.
d. Interaction between condition and practice
1-second task: The interaction was significant 
for the incorrect and missed response rate but not for 
the reaction times.
Although the incorrect response rate increased with 
practice on the task, the difference between the 
percentage of incorrect responses in the baseline and DPH 
conditions were marked. The level of incorrect responses 
in the DPH condition was lower than in the baseline 
condition throughout the session.
Similarly, the missed response rate increased with 
practice on the task, but the level of missed responses 
in the DPH condition was lower than in the baseline 
condition throughout the session.
There was no significant interactions between 
condition and practice for the reaction times. However, 
this might be due to the "ceiling effect" created by the 
task. The maximum .mean reaction time obtained for the
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3-light configurations were approximately 850 raili- 
seconds. In fact, there was not any possibility of an 
increase in the reaction time beyond this limit imposed 
by the task.
5-second task: The interaction was significant for 
the incorrect responses and the reaction times.
The effect of the ©nditions on practice was less 
marked in the 5-second task, but it was significant, 
for the reaction time, the interaction was significant.
The ceiling/effect of the f-second task was eliminated 
in the 5-second task which possibly allowed an interaction 
between conditions and practice to become evident in 
the results. The 1-second task was such that on a 
proportion of trials, the next trial started before the 
subject had responded to the previous one. When the 
inter-stimulus interval was increased to 5 seconds, an 
interaction between practice and condition was revealed.
e. Interaction between practice and configurations
1-second task: The interaction was significant for 
the incorrect and missed response rate and the reaction 
times.
With practice on the task the incorrect and missed 
response rate increased but the level of increase 
depended on the complexity of the configurations.
Similarly, the reaction times increased with practice
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and as a function of stimulus configuration.
5-second task: The interaction was significant for
the incorrect response rate and the reaction times.
f. Interaction between conditions and configurations
V
1-second task: The interaction was significant for
the incorrect and.missed response rates and the reaction
times.
Under both conditions, the incorrect responses 
varied with the complexity of the configurations. However, 
under the DPH condition, the increase in the incorrect 
response rate with stimulus complexity was lower than 
in the baseline condition. This difference was most 
marked when the 5-light configurations were considered.
This effect can also be seen in the results for the 
missed responses.
Reaction times also varied with the complexity 
of the configurations under both conditions. The level of 
reaction times under the DPH condition was markedly 
lower than in the baseline condition. This effect was most 
marked for the reaction times for the 3~light configurations.
5-second task: The interaction was significant for 
the incorrect response rate and the reaction times.
However the level of significance for the reaction times was 
lower (.01<p<.05) probably reflecting the insignificant 
effect of the conditions on performance as a whole.
CHAPTER 7
General Discussion
When a subject is required to decide how to respond 
to a stimulus in a binary classification task with a 
response to the same side or the opposite side of the 
test stimulus position^it has been proposed that he 
will make a number of subsidiary decisions leading to 
the selection of the appropriate response. Those 
subsidiary decisions will reflect the logical state 
coded by the test stimulus, i.e., the stimulus 
configuration on the display.
How does the properties of the particular stimulus 
pattern influence the decisions underlying selection 
of the correct response? To v/hat extent does the 
experimental drug influence the speed and accuracy of 
such decisions? These two questions have been the focal 
point in the experiments described in this thesis.
A summary of main experimental results will be 
followed by a discussion of some of the available 
framework in which to explain the DPIi effect on performance.
In Experiment I, it was shown that accuracy of 
performance was enhanced by DPH when compared to that of 
placebo. But how exactly DPH effect varied with the 
stimulus configurations was not investigated in detail.
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Experiment II investigated the specific characteristics 
of the experimental task in detail. The accuracy of 
performance, as measured by the number of errors and 
the reaction times to the stimulus configurations were 
examined. It v/as shown that the number of errors varie^. 
with the stimulus configurations, and therefore the 
"complexity1 of the decision underlying a response. The 
"easier" the configuration gets, the greater the number 
of correct responses, or vice versa. Reaction time was 
also found to vary with stimulus configurations.
Concerning the data obtained for the 1st and the 2nd 
half of the experiment separately, it was noted that 
performance deteriorated so that a negative practice 
effect was seen. The short inter-stimulus interval used 
in this experiment caused the subjects to miss a 
proportion of trials. Therefore, a time interval which 
would give the subject enough time for deciding about 
his response was employed in Experiment III. It was found 
that both the number of incorrect responses and the 
reaction times decreased, especially for the 3-light 
configurations.
In Experiment II and III, the nature of the task 
situation and the measuring instrument used to evaluate 
DPH effects were established. Experiment IV combined the 
procedures of these previous three experiments. Subjects 
were tested under two different paces of the■task and 
conditions (baseline and DPH) and the number of incorrect
and missed responses and reaction times were measured.
The results indicated the following points: •
1- DPH was effective in reducing the number of ... 
incorrect and missed responses, and reducing the reaction 
times in general in the 1-second task. However, DPH did 
not effect the number of incorrect responses or the ' 
reaction times in the 5-second task.
2- The DPH effect of reducing the number of incorrect 
and missed responses, and reducing the reaction times was 
dependent upon the stimulus configurations.
3- DPH was effective in reducing the performance 
deterioration associated with practice on the 1-second 
task.
A psychotropic drug which is used very extensively in 
clinical and everyday situations can be examined more 
thoroughly when its effects on normal human behaviour 
and performance are investigated in a controlled 
experimental task situation. However, as the usage of 
a drug gets more specialized and confined to clinical 
applications and settings, its effects on specific 
clinical symptoms become the focus of attention, and its 
probable effects on other aspects of normal human 
behaviour and performance are less investigated, or not 
investigated at all. DPH is such a drug with a primary 
application as an anticonvulsant. The reports concerning 
its effects on normal human behaviour and performance
have not been unanimous. Adequate means for explaining 
its effects on normal human behaviour are still to be 
developed.
The problem is to relate drug action which is 
understood best at the level of physiology and biochemistry 
to drug effects., the changes in performance which are 
described in terms of a psychological framework.
There are theories of choice reaction time performance
which seek to explain performance in terms of precise
psychological models of the decision stages underlying
response selection ( 2 ). However the level of the
description of performance employed in this thesis is 
not suitable to interpretation in terms of these models.
Therefore psychological explanations of performance which 
seek rather to define what variables control the general 
level of performance will be reviewed.
One general notion which arose from Information Theory 
as the idea of channel capacity has been developed by 
Kahneman (67) into the more general idea of processing 
capacity.
Kahneman’s theory is one of the current theories of 
attention. He proposes a general theory of factors that 
govern the levels of performance. He assumes that there 
is a general limit on man’s capacity (attention) to 
perform mental work and the amount of this capacity which 
can be deployed at any time is limited.
Capacity varies with the level of arousal and the
demands of the task. A rise in the demands (e.g.,task 
complexity) causes an increase in the level of arousal 
and capacity. Performance of any activity depends on the 
allocation of a certain amount of "effort" to that activity 
hy the (selective) allocation policy. Thus performance . 
is governed by (1) arousal, (2) task demands, and (3) 
motivation which governs the allocation policy. The levels 
of these three elements should be optimal for the optimal 
allocation of effort.
The arousal hypothesis: Several theorists agree that 
the brain stem reticular formation mediates the arousal 
system. The reticular formation receives fibres from the 
main sensory input channels, therefore the level of 
arousal is a direct function of the sensory inputs 
(the level of stimulation) which convey information of 
significance to the organism and to which the organism has 
not habituated. Habituation occurs least easily to novel, 
intense and dangerous inputs. This type of "stressing" 
input can increase arousal and therefore enhance 
performance (174 ).
The fundamental law that relates performance to 
arousal is the Yerkes-Dodson law, which states that as 
arousal increases, so performance improves until some 
optimum point is reached but thereafter performance 
declines. The most important implication of this law 
is the distinction it draws between impairment of 
performance by under- or over-arousal.
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Easterbrook ( 30 ) attempts to explain particularly 
the decrement in performance at high levels of arousal.
He argues that when arousal is low, the selective 
attention to stimulus cues is also low, and irrelevant 
stimulus cues are accepted uncritically for processing. 
When arousal increases, selectivity increases, and 
performance improves because stimulus cues for the task 
are more likely to be rejected. With further increases 
of arousal, the continuing restriction of the range 
of stimulus cues eventually causes relevant stimulus 
cues to be ignored, and performance deteriorates again.
In the context of the present investigation, the
1-second task may be regarded as a highly arousing 
task, whereas the 5-second task a less arousing task, 
because tasks themselves induce a degree of arousal 
which rises with their difficulty (174). it will be 
remembered that in terms of error rate and reaction time, 
performance on the 1-second task is inferior to that 
observed on the 5-second task. This difference could 
be explained by supposing that subjects may be operating 
in an over-aroused state in the 1-second task, while 
in the 5-second task arousal may be closer to optimum.
The results indicate that DPH improves performance in 
the 1-second task, but does not in the 5-second task.
In terms of the present hypothesis this result could be 
explained by supposing that DPH reduces arousal towards 
the optimum level in the 1-second task (pigure 22j.
The literature concerning the effects of DPH on 
arousal is very limited. The human studies with normal 
subjects have used the Critical Flicker Fusion as the 
measure of arousal and reported that various doses of 
DPH did not affect the cFF frequency ( 5 8  , 5 9  ). Howeve^ 
Idestrbm (.58 ) found a significant correlation between 
plasma levels of DPH and the mean level in skin 
conductance. This effect could very possibly be due to 
the anxiety caused by the state-change and not physiologically 
mediated. Idestrbm also found that the direction of the 
correlations throughout the experiment implied that the 
subjective effects of DPH (sedation) tended to be greater 
with high plasma levels. ■
Haward ( so ) reported that DPH raised the stress 
threshold which he explained in terms of the adreno- 
medullary system. The sensitivity of this system to 
stressful situations has been demonstrated in many studies 
( 8 2  , 8 5  , i i 9 ) .  The available literature on DPH indicates 
that it has a regulatory effect on the catecholamine 
levels and this may be relevant to an understanding of 
its effects in controlling hyperexcitability ( 4 5  , 4 6  ).
Haward ( 4 8  ) also reported that DPH improved the ability 
of persons to cope effectively with an experimental 
stress situation, and stated that the stress threshold 
of the subjects had been raised in some degree, indicating 
a regulatory effect of DPH in a stress state.
To summarize these points, the following hypothesis 
of DPH action may be proposed:
_L<f±
1- The 1-second task is a stress-inducing and over- 
arousirg task. The 5-second task is less stress-inducing 
and less arousing task. DPH improves the performance in 
the 1-second task, hut does not affect the other.
2- DPH raises the stress threshold and reduces the v 
level of arousal of subjects in the 1-second task. Its 
effects in the 5-second task is marginal.
3- The subjects in the 1-second task under the effect 
of DPH move back towards the optimum point on the 
curve as shown in Figure 22. Enhancement of performance 
is more pronounced in the 1-second task than in the 
5-second task because of the absolute level of arousal 
with each task. >
In summary, the DPH effect observed in the present 
experiments may be attributed to the drug's ability to 
reduce arousal.
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Figure 22. Hypothetical relationship between arousal 
and performance changes according to the Inverted 
U-Hypothesis.
1-second task □ Baseline H After DPH
5-second task a  Baseline a After DPH
The Selective Attention'hypothesis: A second explanation 
working within Kahneman’s framework can he based on the 
possible effects of DPH as an enhancer of selective 
attention.
Cholinergically active drugs have been found to have 
a profound effect on cognitive processes. Experimental 
animal and human studies have documented that memory and 
cognitive changes may be produced by cholinergically 
active drugs. Cholinergic agonists (e.g.,physostigmine) 
administered into the brain improved, and antagonists 
(e.g.,atropine) impaired learning, discrimination and/or 
memory of experimental animals ( 28 , 106, 172 ). Warburton 
(172) stated that cholinergic agonists may act on the 
components of the learning process, such as attention. The 
Hippocampus may be one of the sites involved, although 
the exact role of this structure still remains largely 
obscure ( 62 ).
Douglas e t . a l , ( 2 6  , 27 ) provide a model which 
relates hippocampal functioning to the efferent control of 
sensory perception which strengthens the tendency to 
ignore irrelevant stimuli by a processing called "gating” 
and enhance relevant stimulus cue selection.
Hippocampal activity is cholinergically mediated, 
and the hippocampus is a crucial link in the cholinergic 
system ( 27 , 92 ).
While a great deal of work has been done using the 
cholinergic agonists, little of value has been discovered
about their effects. The most important reason for this 
is that they have a biphasic effect. They enhance 
cholinergic activity only in low concentrations, and block 
it in high concentrations ( 2 7  ).
A number of investigators have reported that low 
concentrations of DPH enhance the cholinergic activity 
(167,168,183). Furthermore, it has been shown that there 
is a preferential accumulation of DPH in the limbic 
system and especially hippocampal region (107 ,1 o s ,184 ).
In the present study it was found that DPH improved 
performance in the .1-second task but not in the 5-second 
task. This may be explained by supposing that DPH acts 
on the hippocampal gating process and thus helps subjects 
to ignore irrelevant cues and to restrict their capacity 
only to the relevant cues, thereby improving their 
performance.
Unfortunately this hypothesis does not offer an 
explanation of the differential effects of DPH on the two 
forms of the experimental task. DPH should improve selective 
attention in both tasks and therefore improve performance.
The Allocation policy and Motivation hypothesis : The third
explanation which is consistent with Kahneman's framework 
arises from the possible effects of DPH on motivation.
The literature suggest that several different behavioural 
processes may be affected by hippocampal functioning 
including motivation (ei ).
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Differences in motivational level which can change 
the value associated with a task can result in differences 
in the Allocation Policy associated with a task. DPH is 
known to accumulate preferentially in the hippocampus 
and can potentially influence motivation. Therefore
V
changes in performance associated with DPH could result 
from changes in motivation and Allocation Policy which 
governs the uses of resources.
However, this explanation does not lead to a 
differential prediction for the DPH effect on performance in
the experimental tasks. It seems reasonable to expect 
that if motivation is improved with a resulting change 
in Allocation Policy, performance on both tasks will be
At the present time given our limited knowledge of the 
effects of DPH on performance, we must be prepared to accept
that DPH effect can not be easily explained by one approach
alone.
However, it seems reasonable to argue that DPH may
reduce the level of high arousal to an optimum level, thus 
"normalizing" the performance of a hyperexcited subject.
A test of this hypothesis could be made by looking
at the effects of DPH on performance under different
types of stressors.
On empirical grounds, stressors can be categorized
as either psychological (such as self-esteem threats),or
physical (such as noise).
A future study should determine the effects of low
and high stressors on arousal, and the effects of DPH 
on task performance related to arousal level.
failure stress may serve as a psychological stressor, 
and noise as a physical stressor. The experimental task 
could include a Continuous Performance Test as.an v
example of a task demanding sustained attention, and a 
psychomotor task involving both central and peripheral 
mechanisms. Different doses of DPH may be used to 
investigate the dosage effect, physiological and 
biochemical concomitants of arousal and task performance 
may be determined by suitable and available measures.
Appendix 1 
Details of results
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TABLE 12. Correlation between the blood levels of 
DPH and the total number of errors.
Blood Total
Subj .No. Level of er
1 1.17 13
2 1.30 24
3 .54 19
4 1.55 17
5 .66 16
6 3.32 22
7 2.56 43
8 1.76 18
9 .70 20
10 1.34. 32
11 .96 28
12 5.36 37
13 1.10 37
14 .75 10
15 .71 27
16 .94 43
17 4.18 29
18 1.71 4
19 1.87 31
20 3.18 13
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Appendix 2
Technical details of the apparatus
The equipment consists of:
a) Addmaster paper tape reader
b) Subject's light panel
c) Subject's control switches
d) Experimenter's control panel
e) Experimenter's advance switch
f ) Timer
g) 24v power supply
h) 5v logic power supply
i ) Data logger
j ) Event recorder
k) Control unit
Operating procedure: A sequence of light patterns,
predetermined by the experimenter is punched on to the 
paper tape and inserted into the paper tape reader. The 
paper tape is advanced a line at a time by a choice of 3 
methods:
1- By the subject, when he is ready, he presses his 
advance button. The rotary switch on the experimenter's 
control panel must be switched to S (subject).
2- By the experimenter. The plug in experimenter's advance 
button must be plugged into the experimenter's control 
panel and the rotary switch switched to E (experimenter).
3- By a pulse generator (T) in the control unit box, that 
has been set to give a +5 volt pulse once a second. The 
rotary switch is switched to T.
A pattern of lights is shown to the subject, who 
decides which switch is to be pressed(i,e.,left or right), 
and then presses it. If his response is correct, the 
correct responses light comes on for the time that the 
response button is pressed, the correct response counter 
counts and the response counter count, the event recorder 
records that there has been a response and that it is 
correct, the timer displays the subject's reaction time 
and this is recorded by the data logger.
If his response is incorrect, the response counter 
counts, the event recorder records that there has been a 
response, the timer displays the subject's reaction time 
and this is recorded by the data logger.
If there is no response the timer displays the number 
(990 or 4000 msec) and this is recorded by the data logger. 
The event recorder will record every time the paper tape 
reader is advanced.
Combination of lights:
1 represents that light is on.
Left Right Red Green Orange Blue Correct 
White White
1 0 0 0 0 0 L
0 1 0 . 0 0 0 . R
1 0 1 0 0 0 R
0 1 1 0 0 0 L
1 0 0 1 0 0 L
0 1 0 1 0 0 R
1 0 1 0 1 0 L
0 1 1 0 1 0 R
1 0 1 0 0 1 R
0 1 1 0 0 1 L
1 0 0 1 1 0 R
0 1 0 . 1 1 0 L
1 0 0 1 0 1 L
0 1 0 . 1 0 1 R
Circuit operation:
The TTL outputs from the tape reader (logic 1 means a hole) 
are connected to the control unit via the 5 and 6 pin DIN 
plugs. The 6 tape dependent lights are operated from the 
6 pin DIN connectors via transistor drivers. This is 
duplicated on the subject’s display. The 7th track 
indicates the correct response. The 8th track is not used.
If the correct response is made, one of the inputs to 
IC1A goes low and its 0/P goes high. Meanwhile pressing 
either response button causes pin 3 of 8 Way socket to 
go low, is inverted and goes to pin 1 of IC1A causing it 
to go high. Hence the 0/P of the IC1A will be low if the 
correct response is made. This is inverted making pin of 
IClC high. The 0/P of IClC goes to Correct Response Counter 
via a transistor inverter and a driver. The i/p to IClA 
(pin 1) also goes to pin 13 of IC1D, hence it goes high 
when a response button is pressed causing its 0/P to go 
low. This goes via a transistor inverter and a driver 
to the response counter.
If the response is correct then the 0/P from IClC 
sets the bistable formed by IC2A/2B. Pin 4 goes low,pin 6 
high and lights the correct response light via the relay.
The other I/PS to IClC and IC1D are low.
When the advance tape button is depressed, pins 4 and 8 
of the 8 way socket are grounded causing the monostable 
1C3 to be triggered. This gives a pulse of 1 msec for the 
tape reader clock and the tape is advanced 1 sprocket hole. 
When the.timer is advancing the tape, the pulse from the 
timer triggers the monostable, providing the rotary switch 
is correctly positioned.
To record the subject’s response time the circuit in 
Figure 25 is< used.
T1 will advance the paper tape reader, start the 
timer, trigger the event recorder and turn T2 on (the 
output changes from 0 volts to +5 volts and remains up 
for 900 or 4000 msec) once a second. When the subject 
responds, by pressing the button, a positive pulse is 
sent to input 2 of G3- G3’s output will switch from logic 
l(+5 volts) to logic 0(0-volts). This will switch the 
output's of G4 and Gl to logic 1 and so stop the timer v 
and trigger the data logger to record the subject's 
response time. If the subject responds just after the 
allowed maximum response time, his response will not effect 
the timer or data logger because T5 will have been timed 
on by T2 turning off (after 900 msecs or 4000 msecs of the 
start pulse). So input 1 of G3 will now be at logic 0 
and so the positive pulse at input 2 of G3 will not alter 
the output of G3, leaving it at logic 1. As T5 will 
remain on for 200 msec the subject is not able to respond 
in under 150 msec. The reason why T5 was added is so that 
if the subject responds late and presses the switch as 
or just after the 1 second period is up, so the paper 
tape reader will have moved onto the next line, the 
subject's response will be ignored and a. "no response" 
will have been recorded. If the subject does not respond 
the timer will stop at 9u0 msec and the data logger will 
record this time. This is due to T2 turning off after 
900 msec and T3 being turned on. when T3 turns off (after 
10 msec) T4 will turn on and this will reset the timer 
to zero.
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Figure 26. Subject's response/control
switches
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Table 36. connections to tape reader
37 Way 
Connector
6 pin DIN.
5 pin DIN. <
1
2
3
A
5
Sheath
1 ■
2
3
A
5
6
7
8
9 ^
10
11
12 nito 1-8 TTL
13
1
1A
1 15
16-7
17
18
19
20
21
22
23
2A
25
26
27
28 Sprocket TTI.
29 Remote Start
30 Reader Ready
31 Remote Off
32 Clock Enable
33 Forward/Reverse
U
Clock
J5L-[J7 Ground
15 
IG 
3 A
36
37
(Green)
(Mauve)
Bit 8
Clock
+ 2Av
Ground
37 way
Connector to 
Tape Reader
9 Bit 1 (While)
10 Bit 2 (Yellow)
11 Bit 3 (Green)
12 Bit A (Blue)
13 Bit 5 (Black)
1A Bit 6 (Red)
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Appendix 3
A summary of the basic mechanisms of DPH
1. Oh excitable tissues
. \
Merritt and Putnam (io°) were the first investigators 
to discover that DPH was an effective substance when they 
demonstrated that it counteracted electrically-induced 
hyperexcitability in the cat brain. They demonstrated 
DPH’s superiority when compared with bromides and pheno- 
barbitone and also applied their laboratory findings to 
clinical use. They treated a group of chronic epileptic 
patients, who had not responded to treatment with bromides. 
The results were in favour of DPH, since 58% became free 
of attacks and 27% showed improvement but without any 
sedation. Thus, DPH's ability to reduce spread of the 
seizure process from an active focus has been proved both 
experimentally and clinically.
A decade later the demonstration by Toman (15y) that 
DPH prevented the repetitive discharges, which are found 
in the frog sciatic nerve preparation when bathed in low 
calcium ion solution, was one of the earliest electro- 
physiological studies on this drug. This observation 
supported the concept that DPH reduced hyperexcitability 
without blocking normal impulse propagation.
Esplin ( 33 ) using spinal cat preparation, was able
to show that DPH reduced polysynaptic reflex discharges 
recorded from a cut ventral root. In addition, he reported 
that post-tetanic potentiation (PTP) was reduced hy DPH, 
and that the drug had no effect on direct spinal 
facilitation or inhibition. This was the first study of 
its sort, and it established reliable correlations 
between DPH action and descrete effects upon synaptic 
transmission in the nervous system.
A brief explanation of post-tetanic potentiation 
(PTP) is necessary. PTP is a state of hyperexcitability 
of nerve in which following unusually intense stimulation, 
the threshold of the nerve is lowered to subsequent 
stimuli. The nerve fires more easily with less intense 
stimuli. In its most hyperexcitable state, the nerve fires 
spontaneously without stimulus. PTP may be significantly 
concerned in all functions of the nervous system 
characterized by repetitive activity, and that the 
magnitude of its role would seem to be in direct relation 
to the intensity of such repetitive activity ( 3 3 ) .  With 
regard to epilepsy, PTP allows the zone of post-synaptic 
discharge to include neurons not ordinarily concerned in 
a specific pathway. A clear example of this may be seen 
in the spinal cord. During PTP it is possible for 
afferents from one muscle to discharge the moto-neurons 
of another muscle through the mono-synaptic pathway. It 
is therefore likely that the intense activity of a 
seizure focus in the brain leads to potentiation sufficient
to produce activity in pathways not ordinarily excited
♦
by.neurons at the site of the focus (183).
Another study in accord with that of Esplin was by 
Tuttle and Preston (166). They also observed no apparent 
effect of DPH on single-impulse transmission. However,
V
when PTP was produced, it counteracted this state.
The experiments of Raines and Standaert (124,125 ) 
provided further evidence for an effect of DPH on PTP.
In the cat soleus neuromuscular junction, they showed 
that this drug suppresses generation of PTP in the motor 
nerve. In addition in anticonvulsant doses, it also 
abolishes post-tetanic hyperpolarization (PTH) originating 
in the terminals of dorsal root fibers of spinal cord. In 
both these studies recordings were extracellular.
PTH is a fundamental neuronal property and appears to 
be the basic phenomenon that leads to increase of the 
terminal action potential and hence activation of a larger 
proportion of the post-synaptic motor pool which leads to 
PTP.
Julien and Halpern ( 65 ) observed a shortening in the 
recovery period after repetitive stimulation of isolated 
rabbit vagus nerve. This shortening in the recovery period 
was assumed to be correlated with the time course decay of 
the PTH. In a later study, the same authors ( 66 ) studied the 
effect of DPH on firing of cerebellar Purkinje cells and 
their relation to abnormal cortical discharge in cat brain. 
They observed that DPH increased the discharge rate of these
cells, which in turn, produced regulatory effects upon 
abnormally discharging cortical cells, with this study,
DPH is .shown to have a probable effect on cerebellar 
mechanisms as well, since epilepsy is usually thought 
to be associated with malfunctioning of cerebellar '• 
neurons, and most investigators have concentrated on 
cerebrum during their research.
Su and Feldman (154) replicated the studies of Haines 
and Standaert (124,125) but used intracellular recordings 
instead. Using the gracilis anticus muscle of adult rat, 
the authors stated that by using fine capillary micro­
electrodes they were able to pierce the muscle endplates 
and thus to record miniature endplate potentials without 
interfering with the resting membrane potential. Stimulating 
the motor nerve terminal electrically and chemically, the 
authors were able to determine that DPH had a stabilizing 
effect on the excitable membrane of the muscle endplate.
Other studies confirmed these findings in a variety 
of media, i.e., in cat soleus nerve-muscle preparation 
( 3 ,139), in squid giant axon ( 86 ), and in frog neuro­
muscular junction ( 14 ).
In summary, it may be stated that DPH prevents PTP 
by suppressing PTH. A stabilizing effect of DPH is apparent 
on all neuronal membranes.
For example, DPH exerts a marked effect on the 
excitable tissues of the heart and vascular system by 
depressing the myocardial and vascular smooth muscle ( 9 9  ), 
when the system is hyperexcitable.
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Protection against arrhythmias has been reported 
by several authors in chick heart cells ( 149)f in dogs 
(143) and in experimental atrial fibrillation in dogs (22), 
The effect of DPH on skeletal and smooth muscles has 
been the subject of few studies. In cat soleus muscle,
DPH has been reported to suppress the muscle fasciculation 
and twitch potentiation induced by succinylcholine (139 ).
The contraction and spontaneous activity of the 
gastrointestinal smooth muscle in response to various 
agents are markedly diminished by DPH in anticonvulsant 
doses on isolated rabbit intestine ■{ 28*) and on isolated 
ileum of the rat (168).
2 . On electrolyte metabolism
The first indication that DPH affected electrolyte
metabolism was the observations of Woodbury ( isi) that
DPH decreased the sodium ion (Naf) content of.brain, but
had little effect 021 total potassium ion (K1) content.
It also prevented the increase in brain Na and decrease
in K concentrations induced by isosmolar glucose
administered intraperitoneally and that which follows
maximal electroshock seizures. These results led Woodbury
+to postulate that DPH stimulated brain Na transport and
that it might act as an anticonvulsant in this manner.
+
Since active Na transport involves Na-K-ATPase, some 
investigators (126 ) have shown that DPH inhibits Na-K-ATPase 
in brain when the Na/K concentration in the medium is less
than 10:1. However, Gibson and Harris (4 3  ) in human
myocardial microsomal preparations, and sperelakis and
H e n n  (149) in cultured chick heart cells, have shown
that DPH does not alter Na-K-ATPase activity when the
Na/K'ratio is 10:1 or less. On the other hand, Festoff v
and Appel ( 3 5 ) have shown that in synaptosome.preparations
from brain, DPH has a stimulatory effect on Na-K-ATPase
when the Na/K ratio is 25-50:1, whereas a ratio smaller
than this results in no change.
Although the observations on Na-K-ATPase activity
have been conflicting, it may be stated that DPH might
inhibit Na-K-ATPase activity when the Na/K ratio is low
or vice versa.
A correlation between Na-K-ATPase activity and cation
transport has been demonstrated in more than 20 tissues,
including brain (11 ). Na-K-ATPase is present in synaptic
+ +endings which have the ability to transport Na and K 
actively. Enhancement of the activity of this enzyme by 
DPH probably has direct relation to its anticonvulsant 
effects. This is, in particular the case since Escueta 
and Appel ( 32 ) have demonstrated that DPH stimulates
~f*K accumulation in incubated synaptosomes of the cortex.
+
During seizure, neuronal concentration of Na is increased 
+and that of K is decreased. In red blood cells, activity
+of Na-K-ATPase is determined by Na concentration internal
4-
to the membrane and K concentration external to the 
membrane (183). Therefore increased Na and decreased K
concentration in neurons induced by seizures increase 
+ +the Na to K ratio, a situation which in vitro at 
least is favourable for stimulation of Na-K-ATPase 
activity by DPH. Enhanced active transport of Na+ out 
of the cell and K+ into the cell would stabilize the ' 
membrane in the synaptosomes and prevent further 
seizure activity.
Considerable evidence indicates that the PTP 
preventing and membrane stabilizing effects of jjPH 
result from its action on the movement of ions across 
cell membranes.
The basis ofPTP appears to be PTH of the pre- 
synaptic nerve terminals. PTH is understood to the result 
of "sodium pump" activity stimulated by the accumulation 
of intra-cellular sodium excitation. It has been thought 
that the drug probably blocks PTH by enhancing sodium 
pump activity so that no excess accumulation of intra­
cellular sodium during the tetanic stimulation can take 
place ( 183). This limitation of PTP has been considered to 
be of importance in the.prevention■of spread discharge.
The phenomemon of PTP appears to be the result of increased 
transmitter substance released from pre-synaptic terminals, 
and there is evidence that this transmitter release is 
likely to be caused by the movement of calcium into the 
pre-synaptic area during repetitive stimulation (133 ).
3. On biochemical mechanisms
The effects of uPH on amino acid metabolism in 
brain in vivo have been described by Vernadakis and 
Woodbury (170). The most prominent effect is decrease 
in glutamic acid and increase in GABA and glutamine 
concentrations in the brain. Several researchers 
supported this finding ( 5 , i7ij.
Woodbury ( 183) suggests an explanation for this 
effect of DPH. Since conversion of glutamic acid to 
glutamine is an energy-dependent process that requires 
ATP, enhancement of this conversion by DPH suggests that 
this drug makes more energy available for the occurrence 
of such a reaction. This is also in agreement with its 
enhancement of transport of electrolytes, another- energy 
dependent process. It would appear from these facts that 
the availability of high-energy phosphates in increased 
by DPH.
In addition, DPH helps conversion of glutamic acid 
to Krebs Cycle intermediates via formation of alpha-keto- 
glutarate, and therefore enhances protein synthesis.
Experimental evidence indicates that protein synthes 
in skin and gingivae as measured by collagen production 
is also increased by DPH. This is accomplished at the 
expense of fat, which presumably supplies the energy 
for the synthetic process.(Therefore DPH decreases the 
synthesis of lipids, rather than increasing their 
utilization ( 19 , 57' ,108 ).
The effect of DPH on nucleic acid metabolism is 
suggested by the observation that DPH induces folic 
acid deficiency in epileptic patients (1 2 8, 148). This 
would suggest that the interference with the metabolism 
of folic acid is involved in the anticonvulsant effect^ 
of DPH. Part of the deficiency is a result of interference 
of DPH with intestinal absorption of folate polyglutamate
( 132 ).
Since the most striking effect of DPH is to eliminate 
the spread of seizure activity, a process which involves 
synaptic transmission, it seems that part of its action 
is due to an effect on the release, synthesis, storage of 
neurotransmitters.
Small concentrations of DPH increase the release of 
acetylcholine (ACh) from parasympathetic nerve endings 
(16 8). However when the concentration increase DPH 
inhibits the release. Thus a biphasic effect of DPH is 
noted by the authors.
Similar results were reported by several authors, 
leading to the conclusion that DPH may enhance ACh release 
in brain in low concentrations ( 1  , 30 , 12 ).
In conclusion, DPH seems to influence most of the 
body tissues, which indicates a general effect on a basic 
cellular process. Evidence suggests that it plays a role 
in increasing the availability of high-energy phosphates 
for enhancement of active sodium transport and protein 
synthesis.
The most impressive effects of DPH are on excitable 
membranes and tissues, where it stabilizes the membranes. 
The anticonvulsant effect is accomplished largely by 
inhibition of spread of excessive discharges as a result 
of blocking post-tetanic potentiation, an action that v 
accounts for its therapeutic effectiveness in grand mal 
epilepsy. The ability of the drug to stabilize excitable 
membranes also accounts for its anti-arrhythmic effect 
and its depression of smooth muscle.
Appendix 4
Biorhythmicity
It has long been known that animals and humans \
exhibit regular variations in overt behaviour patterns 
closely related to the day/night cycle, called biological 
rhythms.
In humans these rhythms have been demonstrated in 
many processes, amongst them metabolic rate, body 
temperature, heart rate and urine constitution (101).
There is also a marked rhythm in the efficiency of human 
performance.both in normal and unusual environmental 
conditions. The effects of this rhythm appear not only 
when tests are made during the normal waking day, but 
also when they are carried out through the night ( 55 ).
Developed from the concepts of biological rhythms, 
the Biorhythm Theory postulates steadily fluctuating 
rhythms of a physical, emotional and intellectual 
character.
Essentially the theory suggests that man’s performance 
capacity is largely determined by three inherent biological 
rhythms, consisting of a 23-day physical cycle, a 28-day 
emotional cycle, and a 33-day intellectual cycle. 
Theoretically the cycles begin at birth and terminate at 
death. The periodicity is considered to proceed with such 
precision that an individual can calculate his relative
position on the curves strictly on the basis of birthdate.
. ■*)
According to the theory, each cycle begins at zero at the 
moment of birth and progresses in a positive or upward 
direction until a maximum positive value is achieved. At 
this point the cycles begin a return to the zero .pointn 
passing through zero and proceeding into the negative 
portion of a cycle until a maximum negative value is 
achieved. At this point the curve begins the return-to 
zero and the process begins all over again.
The crossover days during which time the curves are 
transitioning from a positive to negative state, have been 
considered critical days. Theoretically during these 
periods performance potential is highly unstable. As the . 
number of curves crossing simultaneously increases, the 
critica'lity associated with this period also increases.
The theory has been applied, to a variety of events 
and situations. However the general approach has consisted 
of attempts at analysing specific events and situations in 
terms of possible biorhythmic influence. The emphasis has 
been placed on attempts to relate the criticality to 
specific events. Neil ( m )  has suggested that the analysis 
should concentrate on the total theoretical rhythmicity 
associated in the theory as opposed to concentrating on 
a partial analysis involving only or primarily the concept 
of criticality. His findings have indicated that the 
distributional form of academic performance and industrial 
accidents were not uniformly distributed, and in some
situations compared favorably with the distribution 
predicted by biorhythms. When industrial accidents were 
dichotomized into lost-time and non-lost-time categories, 
an accident period proneness emerged which correspond 
with the 'theoretical periodicity. In addition, analysis, 
of the hypothetical critical day phenomena indicated that 
a statistically significant number of accidents occurred 
on critical days (111).
The vast majority of research that has been conducted 
on this subject has involved the use of field data in the 
form of accidents ( is , 76 , 1 4 0 , 1 7 7 , 1 7 8). Neil and Sink (112) 
examined the theory under controlled laboratory conditions. 
The results were interpreted as indicating that the 
performance measures used cycled with a considerable 
measure of agreement with the periodicity predicted by 
biorhythms.
The findings indicate that biorhythms may be a 
similar phenomenon as biological rhythms. Although there 
is considerable evidence that some psychological functions 
vary rhythmically, the exact periodicities have not yet 
been scientifically established. Accordingly, no assumption 
was made that the biorhythms of the stated periodicity 
did in fact exist. Rather they were taken as hypothetical 
rhythms, and a null hypothesis was assumed that no 
differences in the experimental variable would be found 
between measurements made at the nadir and acme of the 
hypothetical cycle.
An experiment involving measurements based on a 
hypothetical 33-day cycle.
Subjects:
V
The selection procedure of the subjects was the same 
as explained in 1 .1 . In addition to the interested students' 
willingness to participate, their "intellectual rhythm" 
was calculated. A t  this stage, no acceptance was made that 
such cycles exist, but in order to examine the possibility 
of intra-individual variation due to this phenomenon, it 
was important that the theoretical acme and nadir of the 
hypothetical rhythm was established.
Since a negative and a positive day was needed, it 
was necessary to avoid the coincidence of these with 
weekends, or days inappropriate for the subjects. Being 
cautious in this respect, it was possible for some of the 
subjects to be tested on actual days of maximum theoretical 
amplitude, but for some, the nearest day had to be adjusted 
for their academic schedule. This produced problems in 
the selection of the subjects, and the accumulation of 
subjects took longer then expected. The subjects agreed 
to participate on these fixed dates without knowing the 
presumed significance of them.
30 post-graduate students (26 male,4 female,meanage 
for group 25.6 years) constituted the group.
Conditions:
DPH (Epanutin) in 100 mg capsules and matching placebo
(5 mg DPH) were supplied by Parke-Davis and Co.
30 subjects were divided into two groups according to
\
their biorhythmic condition. Group 1 received DPH and 
placebo at two different acmes of their hypothetical 
cycle, and Group 2 received DPH and placebo at two 
different nadirs.
Within each group, the subjects were counterbalanced. 
Half of the subjects in Group 1 took DPH on the first 
acme, and placebo on the second, for the other half 
this was reversed.
A double-blind cross-over design wasused.
Task:
A binary classification task was used (See para. 3) 
Procedure:
The same procedure as used in the experiment I 
was used (See para 4.3)*
Table 37
Mean scores and standard deviations of sample under 
baseline and drug conditions, and at opposing poles 
of the hypothetical 33-day cycle,and t values.
Pole Baseline I Placebo t Baselinell DPH t
Acme 147.9+ 7.7 145.1+ 5.0 1.2a 147.4+ 6.0 158.8+ 4.6 6. 3*
Nadir 121.2+ 6.0 121.6+ 7.8 . 2a 119.2+ 9.2 140.6+ 4.7 9.7*
t 11.1* f—
'
o
 
■ ► 10.4* 16.5*
a  not significant
* p ^  001
It will be seen from the above table that at each phase of 
the testing a significant difference occurred between the 
measurement made at the acme, and those made at the nadir
of the hypothetical cycle. It will also be noted that these
differences are actually greater than those found between 
DPH and placebo conditions. .
The serious limitation of this type of analysis involves
the use of a single data point for each subject and make the
derivation of rigid quantitative measures of variation within 
each individual difficult. While the results can only be 
suggestive, it appears that the improvement in performance 
produced by the effect of DPH is dependent on the point 
on the hypothetical cycle at which performance was 
measured.
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